Allergic contact dermatitis

L12_ALLERGICCONTACT

allergic contact dermatitis: An inflammatory skin condition caused by an immune response to direct contact between the skin and an allergen. It consists of a delayed type of allergic reaction at the affected site with resulting red, swollen, and blistered skin that may itch or leak.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L23 Hospital discharge: ICD-9 — 6920B\|6921B\|6922B\|6924B\|6924D\|6924H\|6924L\|6925B\|6925D\|6926B\|6926D Cause of death: ICD-10 — L23 Cause of death: ICD-9 — 6920B\|6921B\|6922B\|6924B\|6924D\|6924H\|6924L\|6925B\|6925D\|6926B\|6926D 2 out of 7 registries used, show all original rules.	6109
4. Check minimum number of events None	6109
5. Include endpoints None	6109
6. Filter based on genotype QC (FinnGen only)	6109

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L20-L30
Name in latin: Eczema (allergicum) ex contactu

NAME	L12_ALLERGICCONTACT
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L23
HD_ICD_9	6920B\|6921B\|6922B\|6924B\|6924D\|6924H\|6924L\|6925B\|6925D\|6926B\|6926D
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L23
COD_ICD_9	6920B\|6921B\|6922B\|6924B\|6924D\|6924H\|6924L\|6925B\|6925D\|6926B\|6926D
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Allergic contact dermatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	43120	31110	11862
Only index persons	41106	30055	11051
Unadjusted period prevalence (%)
Whole population	0.73	0.89	0.33
Only index persons	0.92	1.10	0.42
Median age at first event (years)
Whole population	44.15	44.70	42.75
Only index persons	44.01	44.48	42.72

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6109	4783	1326
Unadjusted period prevalence (%)	1.40	1.63	0.58
Median age at first event (years)	47.82	46.67	51.97

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5511: Matched controls
55109

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XQ800

NOMESCO Finland

Prick test

20.5

323.0

2037

1530

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

323.0

950

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

1185.4

323.0

1348

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

521.1

323.0

729

D07AC13

ATC

mometasone; topical

5.7

323.0

2804

8516

L20.0

ICD-10 Finland

Besnier prurigo

+∞

323.0

1377

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

749.3

323.0

831

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

5083.8

323.0

1541

D07AD01

ATC

clobetasol; topical

4.9

323.0

1470

3811

D07AB02

ATC

hydrocortisone butyrate; topical

3.8

323.0

2272

8556

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

+∞

323.0

325

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

304.9

323.0

979

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

32.0

323.0

2929

1887

L30.3

ICD-10 Finland

Infective dermatitis

34.0

323.0

544

177

D07AC01

ATC

betamethasone; topical

5.2

323.0

2958

10089

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

1141.9

323.0

1100

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

932.4

323.0

509

D07AB08

ATC

desonide; topical

6.7

323.0

1171

2128

E000001

ATC

5.5

323.0

2087

5508

E0000UV

ATC

6.1

323.0

3620

13186

XQ802

NOMESCO Finland

Epicutan test

257.5

323.0

2742

211

L30.9

ICD-10 Finland

Dermatitis, unspecified

16.0

323.0

2595

2900

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

4.9

320.2

1187

2905

E000002

ATC

5.1

319.2

1135

2654

D07BC01

ATC

betamethasone and antiseptics; topical

5.1

312.1

1118

2630

L20

ICD-10 Finland

Atopic dermatitis

+∞

283.8

270

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

9.8

265.3

565

635

R06AE07

ATC

cetirizine; oral

2.6

252.8

3056

17638

D07AA02

ATC

hydrocortisone; topical

4.0

249.8

1150

3396

D07CC01

ATC

betamethasone and antibiotics; topical

4.0

241.8

1128

3360

H02AB06

ATC

prednisolone; systemic

2.6

237.1

2901

16619

D02AE01

ATC

carbamide; topical

5.9

225.4

683

1289

D11AH01

ATC

tacrolimus; topical

1063.0

210.7

205

E000006

ATC

5.1

203.3

699

1521

R06AX27

ATC

desloratadine; oral

2.5

189.9

2028

10392

D07BA04

ATC

hydrocortisone and antiseptics; topical

4.0

183.9

812

2257

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

468.0

183.2

182

E000003

ATC

6.9

182.8

484

756

L30.8

ICD-10 Finland

Other specified dermatitis

15.1

173.3

296

206

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.5

167.2

644

1564

D02AX

ATC

Other emollients and protectives

8.3

166.4

388

499

TQW80

NOMESCO Finland

Local dermatologic skincare

12.9

156.3

286

233

E000007

ATC

5.2

154.4

519

1087

L30.0

ICD-10 Finland

Nummular dermatitis

11.0

152.3

301

288

R06AE09

ATC

levocetirizine; oral

2.8

145.8

1115

4599

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.5

142.1

1406

6704

D07XC01

ATC

betamethasone, combinations; topical

3.3

141.1

796

2666

D09AB01

ATC

zinc bandage without supplements; topical

16.3

140.9

233

149

L23

ICD-10 Finland

Allergic contact dermatitis

30.1

133.4

181

E000004

ATC

10.0

133.2

277

291

L23.4

ICD-10 Finland

Allergic contact dermatitis due to dyes

430.7

127.4

127

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

38.7

123.6

158

L20.8

ICD-10 Finland

Other atopic dermatitis

+∞

119.2

114

L24.8

ICD-10 Finland

Irritant contact dermatitis due to other agents

402.7

119.1

119

R06AX22

ATC

ebastine; oral

2.4

114.8

1214

5895

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

92.1

113.5

126

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

22.3

111.9

165

D07AC14

ATC

methylprednisolone aceponate; topical

4.7

111.1

403

908

T78.4

ICD-10 Finland

Allergy, unspecified

4.3

111.0

438

1073

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

+∞

107.6

103

S87

ICPC

Dermatitis/atopic eczema

9.3

106.5

229

255

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

3.9

103.0

463

1276

C01CA24

ATC

epinephrine; parenteral

3.4

101.7

530

1649

J01DB01

ATC

cefalexin; oral

2.1

100.7

4542

38146

R03AC02

ATC

salbutamol; inhalant

1.8

94.9

2991

21879

L50.3

ICD-10 Finland

Dermatographic urticaria

8.9

94.8

209

243

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

+∞

91.9

L23.6

ICD-10 Finland

Allergic contact dermatitis due to food in contact with skin

141.0

91.3

D11AX14

ATC

[U] tacrolimus; topical

+∞

90.9

N05BB01

ATC

hydroxyzine; systemic

3.4

89.3

467

1452

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

51.9

88.9

107

S01GX01

ATC

cromoglicic acid; ophthalmic

2.1

88.8

1291

7122

L23.7

ICD-10 Finland

Allergic contact dermatitis due to plants, except food

292.9

84.9

R06AX13

ATC

loratadine; oral

2.1

77.3

1011

5294

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.7

76.4

574

2272

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.9

74.1

505

1881

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.3

73.0

798

3846

J01DA01

ATC

[U] cefalexin; systemic

1.7

73.0

3435

27310

D11AH02

ATC

pimecrolimus; topical

+∞

71.0

J01FF01

ATC

clindamycin; systemic

1.8

70.8

1464

9082

H02AB07

ATC

prednisone; oral

2.2

70.6

798

3903

D05BB02

ATC

acitretin; oral

7.3

68.5

171

242

WIX00

NOMESCO Finland

Allergy cleanup guidance

145.8

68.1

XQ899

NOMESCO Finland

Other assessment of skin

22.9

68.0

H02AB04

ATC

methylprednisolone; systemic

2.1

62.7

810

4182

R03DC03

ATC

montelukast; oral

2.0

62.4

953

5266

L27.2

ICD-10 Finland

Dermatitis due to ingested food

113.0

61.9

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.9

61.2

266

707

D07AB01

ATC

clobetasone; topical

4.2

60.4

241

592

XQ848

NOMESCO Finland

Dermatological photography

5.8

60.0

177

314

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

60.0

926

5131

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

14.6

56.2

S88

ICPC

Dermatitis contact/allergic

5.3

55.9

177

342

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

34.7

55.4

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

13.1

54.4

R03BA05

ATC

fluticasone; inhalant

1.8

53.6

1010

5985

J30.3

ICD-10 Finland

Other allergic rhinitis

3.4

51.0

265

815

SPAT1263

SPAT

Sampling

1.6

50.3

2199

16472

L50.8

ICD-10 Finland

Other urticaria

5.2

50.3

163

324

L29.9

ICD-10 Finland

Pruritus, unspecified

6.3

50.1

138

225

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

49.8

950

5637

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.3

49.1

266

844

L50.9

ICD-10 Finland

Urticaria, unspecified

3.4

48.5

248

753

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

12.4

48.2

L28.0

ICD-10 Finland

Lichen simplex chronicus

26.1

48.1

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

18.1

47.9

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

13.1

47.7

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

8.2

47.6

109

136

S29

ICPC

Skin symptom/complaint other

1.9

47.0

818

4695

6924B

ICD-9 Finland

Contact dermatitis and other eczema, Due to other chemical products[DERMATITIS ARTEFACTA E METALLIS ALLERGICA]

+∞

46.9

Z3231

NOMESCO Finland

Registered nurse

1.7

46.1

1320

8831

L50.0

ICD-10 Finland

Allergic urticaria

3.9

45.3

196

519

D07XB05

ATC

dexamethasone, combinations; topical

4.1

44.9

182

455

R01AD09

ATC

mometasone; nasal

1.5

43.3

2455

19282

A46

ICD-10 Finland

Erysipelas

2.1

43.2

566

2913

WQ007

NOMESCO Finland

80.8

42.9

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.0

42.1

260

903

J01AA04

ATC

lymecycline; systemic

1.8

42.1

765

4444

D11AX15

ATC

[U] pimecrolimus; topical

+∞

41.7

N02BE01

ATC

paracetamol; systemic, rectal

1.6

41.5

4483

40306

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

41.2

1292

8810

L28.1

ICD-10 Finland

Prurigo nodularis

60.5

41.2

J01AA02

ATC

doxycycline; systemic

1.5

40.0

4022

35338

R01AD08

ATC

fluticasone; nasal

1.5

39.6

1541

11064

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

39.3

630

3495

A02BC02

ATC

pantoprazole; systemic

1.5

39.3

3167

26511

R06.0

ICD-10 Finland

Dyspnoea

1.6

39.2

1098

7254

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

39.0

1051

6869

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

2.0

38.7

520

2698

D07CB01

ATC

triamcinolone and antibiotics; topical

4.3

38.5

149

357

J01AA07

ATC

tetracycline; systemic

1.7

38.5

860

5324

J02AC01

ATC

fluconazole; systemic

1.5

38.4

2351

18591

A92

ICPC

Allergy/allergic reaction NOS

3.4

37.9

191

574

D05AX52

ATC

calcipotriol, combinations; topical

2.6

37.3

282

1111

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

3.7

37.1

169

469

L21.0

ICD-10 Finland

Seborrhoea capitis

9.8

34.9

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

34.6

1408

10151

M25.5

ICD-10 Finland

Pain in joint

1.5

34.6

1456

10577

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

5.4

34.3

106

201

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

34.1

617

3560

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

5.0

34.0

111

224

D11AH04

ATC

alitretinoin; oral

176.0

33.7

L71.8

ICD-10 Finland

Other rosacea

4.9

33.7

113

235

XQ801

NOMESCO Finland

Intracutantest

11.1

33.6

D06BX01

ATC

metronidazole; topical

1.9

33.5

571

3230

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.7

33.0

233

879

J02AC02

ATC

itraconazole; systemic

1.6

32.6

923

6077

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

32.3

1789

13722

J45

ICD-10 Finland

Asthma

1.9

32.1

487

2638

R03BA02

ATC

budesonide; inhalant

1.6

31.9

872

5687

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

4.6

31.9

113

249

L29.8

ICD-10 Finland

Other pruritus

8.0

31.4

A02BC05

ATC

esomeprazole; systemic

1.4

31.4

1940

15177

XQ820

NOMESCO Finland

Exposure to medicinal substance

13.2

31.3

M79.6

ICD-10 Finland

Pain in limb

1.4

31.2

1718

13144

G47.3

ICD-10 Finland

Sleep apnoea

1.6

30.7

880

5804

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.8

30.6

208

769

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

30.6

1875

14626

6925B

ICD-9 Finland

Contact dermatitis and other eczema, Due to food in contact with skin[DERMATITIS ARTEFACTA EX ALIMENTIS ALLERGICA,VÄLITÖN]

+∞

30.2

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

30.2

1797

13930

L26

ICD-10 Finland

Exfoliative dermatitis

304.0

29.8

D07AC03

ATC

desoximetasone; topical

4.5

29.7

108

245

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.5

29.7

1412

10465

M54.5

ICD-10 Finland

Low back pain

1.4

28.8

1622

12419

S21

ICPC

Skin texture symptom/complaint

1.8

28.5

551

3241

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

28.4

2348

19251

E0001A1

ATC

3.2

27.9

149

470

WZC30

NOMESCO Finland

Teaching

1.7

27.9

589

3560

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

27.4

815

5411

R03BA08

ATC

ciclesonide; inhalant

1.9

27.4

416

2252

H01.0

ICD-10 Finland

Blepharitis

2.2

27.3

290

1358

L43.8

ICD-10 Finland

Other lichen planus

4.1

27.3

108

266

S01GX02

ATC

levocabastine; ophthalmic

2.0

26.8

338

1704

M03BX02

ATC

tizanidine; oral

1.4

26.7

3215

27929

L24.5

ICD-10 Finland

Irritant contact dermatitis due to other chemical products

97.2

26.7

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.9

26.5

170

607

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

26.2

1123

8111

R51.80

ICD-10 Finland

Headache

1.6

25.6

762

5056

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

25.6

454

2595

J01FA10

ATC

azithromycin; systemic

1.4

25.6

3112

26986

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

25.6

480

2795

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

25.5

556

3391

J01MA12

ATC

levofloxacin; systemic

1.6

25.4

745

4922

SPAT1283

SPAT

Restricted health certificate

1.5

25.4

1027

7320

R06AX18

ATC

acrivastine; oral

2.8

25.3

163

584

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

+∞

25.0

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.8

24.8

442

2530

A07AA02

ATC

nystatin; oral

2.1

24.7

276

1322

L71.9

ICD-10 Finland

Rosacea, unspecified

3.2

24.7

132

418

S02

ICPC

Pruritus

2.7

24.7

171

640

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

24.4

475

2793

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.6

24.3

186

L56.4

ICD-10 Finland

Polymorphous light eruption

11.0

24.3

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

+∞

24.0

J01FA06

ATC

roxithromycin; oral

1.4

23.7

1955

15866

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

23.5

1156

8562

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

+∞

22.9

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

22.9

487

2945

R01AD12

ATC

fluticasone furoate; nasal

1.4

22.9

1556

12211

Z50.1

ICD-10 Finland

Other physical therapy

2.1

22.8

263

1278

J05AB01

ATC

aciclovir; systemic

1.5

22.7

1026

7461

J01MA02

ATC

ciprofloxacin; systemic

1.4

22.5

1638

12995

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

22.5

774

5307

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

22.4

1963

16044

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

4.7

22.3

167

S18

ICPC

Laceration/cut

1.4

22.1

1771

14263

SPAT1153

SPAT

Removal of sutures

1.4

21.9

1352

10418

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

21.6

591

3831

R03AC03

ATC

terbutaline; inhalant

1.6

21.5

662

4415

G44.2

ICD-10 Finland

Tension-type headache

1.6

21.5

671

4493

SPAT1301

SPAT

No procedures

1.4

21.5

1384

10736

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

21.4

1041

7676

J01FA09

ATC

clarithromycin; systemic

1.4

21.3

1583

12577

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.5

21.3

102

298

R96

ICPC

Asthma

1.8

21.3

389

2243

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

20.9

1144

8617

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

20.9

373

2135

J01CF05

ATC

flucloxacillin; systemic

2.4

20.8

178

750

L71.0

ICD-10 Finland

Perioral dermatitis

3.4

20.7

100

294

D05AX03

ATC

calcitriol; topical

4.1

20.5

201

R06AX26

ATC

fexofenadine; oral

1.8

20.5

355

2009

M01AH05

ATC

etoricoxib; oral

1.3

20.5

2912

25432

A02BC01

ATC

omeprazole; systemic

1.4

20.5

1173

8905

Z01.2

ICD-10 Finland

Dental examination

1.3

20.1

2058

17142

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

20.0

789

5560

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

19.8

3665

33132

J01FA01

ATC

erythromycin; systemic

1.5

19.8

734

5105

R42

ICD-10 Finland

Dizziness and giddiness

1.5

19.8

882

6377

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

+∞

19.8

UJF32

NOMESCO Finland

Coloscopy

1.4

19.6

1030

7687

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

19.3

680

4674

S06

ICPC

Rash localized

2.0

19.2

236

1178

P01AB01

ATC

metronidazole; oral, rectal

1.3

19.2

1980

16472

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

19.2

3344

29903

SPAT1310

SPAT

Counselling related to known health issue

1.4

19.1

1445

11472

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

19.1

889

6481

SPAT1260

SPAT

Consultation of another employee

1.5

19.1

771

5461

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.4

18.9

273

N02AX02

ATC

tramadol; systemic, rectal

1.3

18.7

1804

14849

L17

ICPC

Foot/toe symptom/complaint

1.4

18.6

1092

8303

R05

ICPC

Cough

1.4

18.6

1015

7622

M01AE02

ATC

naproxen; oral, rectal

1.3

18.5

2846

24963

L43.9

ICD-10 Finland

Lichen planus, unspecified

3.5

18.5

252

N03AX16

ATC

pregabalin; oral

1.4

18.4

1006

7550

R02

ICPC

Shortness of breath/dyspnoea

1.6

18.4

475

3028

SPAT1059

SPAT

Spirometry at the office

2.0

18.4

225

1122

L04AD01

ATC

ciclosporin; systemic

3.2

18.3

307

X58

ICD-10 Finland

Exposure to other specified factors

1.5

18.3

592

3993

M79.1

ICD-10 Finland

Myalgia

1.5

17.9

599

4070

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

17.8

195

928

N03AX12

ATC

gabapentin; oral

1.5

17.8

666

4640

L30.4

ICD-10 Finland

Erythema intertrigo

5.3

17.8

103

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

17.8

244

1274

J20

ICD-10 Finland

Acute bronchitis

1.7

17.7

419

2609

69240

ICD-8 Finland

Other eczema and dermatitis, Due to other chemicals

+∞

17.7

SPAT1312

SPAT

General health counselling

1.3

17.7

1493

12030

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

17.6

1888

15739

D05AX02

ATC

calcipotriol; topical

2.3

17.5

165

734

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

17.4

1872

15608

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.6

17.3

531

3534

XG410

NOMESCO Finland

Flow-volume spirometry

2.2

17.1

169

769

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

17.0

397

2459

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

17.0

535

3584

J01DB05

ATC

cefadroxil; oral

2.1

16.9

200

983

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

16.8

1212

9519

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

16.8

733

5268

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

16.8

2740

24089

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

2.3

16.7

161

725

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

16.7

1522

12379

L24.3

ICD-10 Finland

Irritant contact dermatitis due to cosmetics

+∞

16.7

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.7

16.6

362

2204

395

Kela drug reimbursment

Dupilumab

90.3

16.6

L30

ICD-10 Finland

Other dermatitis

2.9

16.5

337

Z51.6

ICD-10 Finland

Desensitization to allergens

3.7

16.5

197

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

16.4

1785

14874

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

16.4

2625

22990

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.2

16.4

169

785

SPAT1058

SPAT

PEF monitoring instruction

1.7

16.3

354

2151

L08.0

ICD-10 Finland

Pyoderma

5.1

16.3

101

M01AB05

ATC

diclofenac; systemic, rectal

1.3

16.3

3270

29448

D11

ICPC

Diarrhoea

1.5

16.2

533

3606

SPAT1211

SPAT

Application of soft bandage

1.7

16.2

372

2296

XQ817

NOMESCO Finland

30.1

16.1

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

16.1

2380

20625

A02BC03

ATC

lansoprazole; oral

1.3

15.9

1241

9853

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

15.9

179

862

L03

ICPC

Low back symptom/complaint

1.4

15.9

1082

8410

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

15.8

367

2270

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

7.7

15.8

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

15.8

290

1675

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

15.6

2115

18102

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

15.6

731

5321

R05

ICD-10 Finland

Cough

1.4

15.6

825

6140

J01XC01

ATC

fusidic acid; systemic

3.4

15.5

224

H10.5

ICD-10 Finland

Blepharoconjunctivitis

2.9

15.4

318

SBB10

NOMESCO Finland

Teeth copy

1.8

15.4

285

1649

R21

ICPC

Throat symptom/complaint

1.4

15.3

1007

7780

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

15.2

1636

13584

R74

ICPC

Upper respiratory infection acute

1.3

15.1

1460

11942

WQ021

NOMESCO Finland

20.1

15.1

WQ020

NOMESCO Finland

45.1

15.0

L40.8

ICD-10 Finland

Other psoriasis

5.5

15.0

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

15.0

303

1802

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

15.0

402

2582

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

15.0

962

7396

134

Kela drug reimbursment

General erythroderma

12.4

14.8

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.6

14.8

395

2536

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

14.8

1479

12148

A02BA02

ATC

ranitidine; systemic

1.4

14.6

761

5644

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

5.7

14.6

H01

ICPC

Ear pain/earache

1.5

14.6

486

3295

S01GX05

ATC

lodoxamide; ophthalmic

3.1

14.6

262

C03CA01

ATC

furosemide; systemic

1.4

14.6

822

6185

SPAT1254

SPAT

Administration of medicine

1.5

14.5

549

3823

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

14.4

1382

11284

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

14.4

272

1586

A02BC04

ATC

rabeprazole; oral

1.6

14.3

379

2429

WQ000

NOMESCO Finland

Hyposensibilisation

5.7

14.3

L01

ICPC

Neck symptom/complaint

1.4

14.2

613

4386

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

14.1

263

1526

L25.8

ICD-10 Finland

Unspecified contact dermatitis due to other agents

42.6

14.1

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

14.1

722

5337

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

5.6

14.0

R53

ICD-10 Finland

Malaise and fatigue

1.4

13.9

831

6308

T78.3

ICD-10 Finland

Angioneurotic oedema

3.2

13.8

228

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

13.8

274

1621

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

13.8

456

3085

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

13.7

330

2063

ZXX06

NOMESCO Finland

Extent of procedure, 6 units

8.6

13.7

D11AH05

ATC

dupilumab; topical

75.3

13.6

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.8

13.6

249

1440

6924D

ICD-9 Finland

Contact dermatitis and other eczema, Due to other chemical products[DERMATITIS ARTEFACTA E CHEMICALIBUS GUMMI ALLERGICA]

+∞

13.5

R01AD01

ATC

beclometasone; nasal

1.4

13.5

690

5098

A03

ICPC

Fever

1.4

13.5

751

5633

F29

ICPC

Eye symptom/complaint other

1.6

13.4

341

2165

K30

ICD-10 Finland

Functional dyspepsia

1.5

13.4

448

3037

R01AD11

ATC

triamcinolone; nasal

1.5

13.3

411

2736

R01AD05

ATC

budesonide; nasal

1.6

13.2

352

2259

R03BB04

ATC

tiotropium bromide; inhalant

1.7

13.1

298

1837

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

13.1

575

4125

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

13.0

1177

9506

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

13.0

380

2496

D01BA02

ATC

terbinafine; oral; topical

1.3

12.9

963

7570

L08

ICPC

Shoulder symptom/complaint

1.4

12.8

760

5758

S76

ICPC

Skin infection other

1.9

12.8

184

981

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.4

12.8

105

437

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

12.8

1115

8959

H03AA01

ATC

levothyroxine sodium; systemic

1.3

12.7

1089

8725

N06AX21

ATC

duloxetine; oral

1.5

12.7

483

3368

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

12.7

158

799

J02AB02

ATC

ketoconazole; oral

2.1

12.6

139

666

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

15.4

12.6

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

3.5

12.5

169

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

5.5

12.5

A05

ICPC

Feeling ill

1.7

12.5

260

1564

L12

ICPC

Hand/finger symptom/complaint

1.4

12.4

596

4349

M02AA07

ATC

piroxicam; topical

1.3

12.4

1514

12699

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

12.4

2848

25649

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.9

12.3

247

R03AC13

ATC

formoterol; inhalant

1.8

12.3

205

1149

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

12.3

1346

11140

L93.0

ICD-10 Finland

Discoid lupus erythematosus

7.1

12.2

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

12.2

2473

21959

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

12.2

1453

12144

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.8

12.2

278

WX290

NOMESCO Finland

Other blockade of nerve

1.2

12.2

2213

19423

R03BA01

ATC

beclometasone; inhalant

1.4

12.1

584

4263

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

12.1

378

2521

K07.60

ICD-10 Finland

Snapping jaw

1.7

12.1

248

1485

S01AD03

ATC

aciclovir; ophthalmic

2.0

12.0

157

809

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.3

11.9

112

502

L28

ICPC

Limited function/disability (L)

1.4

11.9

513

3667

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

11.9

345

2264

X57

ICD-10 Finland

Unspecified privation

2.5

11.9

361

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

11.8

934

7392

SPAT1262

SPAT

Handing over of treatment supplies

1.4

11.7

644

4810

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

11.7

107

473

L28.2

ICD-10 Finland

Other prurigo

16.4

11.6

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

11.6

152

783

QX_2

NOMESCO Finland

Other diagnostic procedures of skin

65.1

11.6

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

11.6

164

872

D01AC02

ATC

miconazole; topical

1.6

11.5

270

1679

WXQ24

NOMESCO Finland

UVB/UVA light therapy

+∞

11.5

XG405

NOMESCO Finland

Education on PEF monitoring

2.8

11.4

253

R52.9

ICD-10 Finland

Pain, unspecified

1.6

11.4

335

2207

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

11.4

280

1764

J05AB11

ATC

valaciclovir; oral

1.4

11.3

558

4086

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

11.3

402

2761

G01AF05

ATC

econazole; vaginal

1.5

11.3

416

2881

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

11.3

533

3877

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

8.3

11.3

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.7

11.2

273

H60.8

ICD-10 Finland

Other otitis externa

2.1

11.2

119

563

R60.0

ICD-10 Finland

Localized oedema

1.5

11.2

374

2538

B35.3

ICD-10 Finland

Tinea pedis

2.0

11.1

143

733

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.5

11.0

331

2193

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

11.0

292

1877

R06AX11

ATC

astemizole; oral

2.0

11.0

138

700

A10AE05

ATC

insulin detemir; parenteral

1.7

10.9

207

1210

Z00.0

ICD-10 Finland

General medical examination

1.3

10.8

732

5655

R06AE08

ATC

3.2

10.7

174

C05AA08

ATC

fluocortolone; rectal, topical

1.4

10.7

569

4226

H29

ICPC

Ear symptom/complaint other

1.5

10.7

370

2528

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

10.7

172

954

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.3

10.7

100

448

K02.1

ICD-10 Finland

Caries of dentine

1.2

10.7

2789

25278

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.9

10.6

215

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

10.5

1845

16060

WX110

NOMESCO Finland

Local anesthesy

1.2

10.4

3421

31670

6924L

ICD-9 Finland

Contact dermatitis and other eczema, Due to other chemical products[DERMATITIS ARTEFACTA E ODORIFERIS ALLERGICA]

+∞

10.4

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

+∞

10.4

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.5

10.4

314

R06.2

ICD-10 Finland

Wheezing

1.8

10.4

171

957

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

10.3

504

3685

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.3

10.3

430

L16

ICPC

Ankle symptom/complaint

1.5

10.3

411

2893

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.9

10.3

213

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

10.3

1641

14133

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

10.3

289

1887

C07AB07

ATC

bisoprolol; oral

1.2

10.2

1651

14238

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

10.2

2058

18155

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

10.2

226

1386

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.6

10.2

286

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

10.2

1000

8138

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

10.1

458

3301

L56.8

ICD-10 Finland

Other specified acute skin changes due to ultraviolet radiation

13.1

10.1

L43.0

ICD-10 Finland

Hypertrophic lichen planus

5.0

10.1

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

10.1

350

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

10.1

325

2187

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

10.1

341

2321

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

10.1

605

4584

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

10.0

157

864

S99

ICPC

Skin disease other

2.5

10.0

301

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

9.9

333

2260

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

9.9

1257

10546

D07XB01

ATC

flumetasone, combinations; topical

4.4

9.9

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

9.9

244

1540

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.2

9.9

100

466

A01AB09

ATC

miconazole; local oral

1.5

9.9

341

2333

L21

ICD-10 Finland

Seborrhoeic dermatitis

3.0

9.8

175

49300

ICD-8 Finland

Asthma, bronchiale

2.3

9.8

382

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

3.4

9.8

132

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

9.8

270

1755

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.9

9.8

149

813

SPAT1104

SPAT

Monitoring of emergency patient

1.6

9.8

235

1474

S01GX04

ATC

nedocromil; ophthalmic

2.4

9.7

339

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

9.7

485

3565

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

9.7

1813

15856

S01GX09

ATC

olopatadine; ophthalmic

2.0

9.6

112

552

A77

ICPC

Viral disease other/NOS

1.8

9.6

159

896

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

9.5

811

6471

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

9.5

224

1396

J45.8

ICD-10 Finland

Mixed asthma

2.0

9.5

118

598

L29.0

ICD-10 Finland

Pruritus ani

4.0

9.5

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.6

9.5

222

1383

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

9.5

714

5602

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

9.4

330

2261

L15

ICPC

Knee symptom/complaint

1.3

9.4

826

6615

H10.4

ICD-10 Finland

Chronic conjunctivitis

3.2

9.4

147

WX722

NOMESCO Finland

PEEP

1.8

9.4

158

894

S01GX08

ATC

ketotifen; ophthalmic

1.8

9.4

161

913

J01MA14

ATC

moxifloxacin; systemic

1.5

9.4

318

2164

J01CA04

ATC

amoxicillin; systemic

1.2

9.4

4157

39390

R01AC01

ATC

cromoglicic acid; nasal

1.7

9.4

174

1016

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

9.4

256

1661

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

9.3

1293

10945

L13.9

ICD-10 Finland

Bullous disorder, unspecified

5.3

9.3

R07.0

ICD-10 Finland

Pain in throat

1.6

9.3

263

1718

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

1.6

9.3

214

1328

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

9.3

1494

12848

L04AX01

ATC

azathioprine; systemic

1.8

9.3

166

958

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.0

9.3

121

627

K11.2

ICD-10 Finland

Sialoadenitis

1.9

9.2

129

685

S02CA02

ATC

flumetasone and antiinfectives; otic

1.6

9.2

211

1309

N06AB04

ATC

citalopram; systemic

1.3

9.2

910

7407

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

9.1

225

1421

N01

ICPC

Headache

1.4

9.1

465

3426

D07AB09

ATC

triamcinolone; topical

4.3

9.1

Z2446

NOMESCO Finland

Social worker

1.6

9.0

252

1640

XQ811

NOMESCO Finland

Exposure to latex

36.7

9.0

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

9.0

690

5426

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

9.0

526

3969

S01GX06

ATC

emedastine; ophthalmic

2.6

9.0

246

M79.7

ICD-10 Finland

Fibromyalgia

1.7

9.0

163

946

L57.8

ICD-10 Finland

Other skin changes due to chronic exposure to nonionizing radiation

7.4

8.9

J37.0

ICD-10 Finland

Chronic laryngitis

1.9

8.9

128

687

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

8.9

147

828

R03AC12

ATC

salmeterol; inhalant

1.8

8.8

147

829

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

8.8

143

799

UDM02

NOMESCO Finland

Sinoscopy

2.2

8.8

422

SXC05

NOMESCO Finland

Other oral or dental procedure

1.6

8.8

240

1559

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

8.7

970

7999

L70.0

ICD-10 Finland

Acne vulgaris

2.0

8.7

110

562

ZY010

NOMESCO Finland

Hospital outpatient

1.6

8.7

203

1265

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.7

8.7

188

1147

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

8.7

856

6956

L73.8

ICD-10 Finland

Other specified follicular disorders

3.7

8.7

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

8.6

757

6061

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.5

8.6

269

1802

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

5.0

8.6

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

8.6

299

2048

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

8.6

203

1270

R29

ICPC

Respiratory symptom/complaint other

1.6

8.5

242

1582

RJ411

NOMESCO Finland

4.4

8.5

SPAT1216

SPAT

Assessment of functional ability

1.4

8.5

481

3612

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.2

8.5

383

R07.3

ICD-10 Finland

Other chest pain

1.5

8.5

318

2213

H60

ICD-10 Finland

Otitis externa

1.7

8.5

187

1147

L50

ICD-10 Finland

Urticaria

2.3

8.4

324

L24.1

ICD-10 Finland

Irritant contact dermatitis due to oils and greases

90.2

8.4

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.5

8.4

318

2218

L04AA01

ATC

[U] ciclosporin; systemic

2.6

8.3

217

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.9

8.3

165

6924N

ICD-9 Finland

Contact dermatitis and other eczema, Due to other chemical products[DERMATITIS ARTEFACTA E CHEMICALIBUS ALIIS ALLERGICA]

+∞

8.3

6928B

ICD-9 Finland

Contact dermatitis and other eczema, Due to other specified agents[DERMATITIS ARTEFACTA E COSMETICA ALLERGICA]

+∞

8.3

S01

ICPC

Pain/tenderness of skin

1.7

8.3

150

870

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

8.3

1136

9585

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

8.3

238

1560

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

8.3

224

1448

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

8.3

551

4241

R00.2

ICD-10 Finland

Palpitations

1.5

8.3

297

2046

S80.0

ICD-10 Finland

Contusion of knee

1.5

8.3

268

1810

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

8.3

2003

17873

L50.5

ICD-10 Finland

Cholinergic urticaria

10.7

8.3

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

8.3

378

2735

R01AC02

ATC

levocabastine; nasal

1.9

8.3

123

670

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.1

8.3

395

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

8.2

220

1419

L50.1

ICD-10 Finland

Idiopathic urticaria

3.5

8.2

103

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

8.2

183

1129

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

8.2

1082

9097

M77.0

ICD-10 Finland

Medial epicondylitis

1.9

8.2

106

549

R05FB02

ATC

cough suppressants and expectorants

1.2

8.2

1603

14025

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

8.1

403

2960

R03AK11

ATC

formoterol and fluticasone; inhalant

2.0

8.1

501

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

8.1

392

2863

R09

ICPC

Sinus symptom/complaint

1.4

8.1

347

2480

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.0

8.1

488

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

8.1

842

6884

D73

ICPC

Gastroenteritis presumed infection

1.8

8.1

129

721

R51

ICD-10 Finland

Headache

1.6

8.0

223

1454

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

8.0

1082

9112

R13

ICD-10 Finland

Dysphagia

1.6

8.0

204

1302

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

8.0

336

2390

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.6

8.0

181

1118

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.5

8.0

239

1585

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

8.0

364

2631

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.8

8.0

139

797

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

7.9

172

1051

A04

ICPC

Weakness/tiredness general

1.3

7.9

472

3575

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

7.9

567

4412

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

7.9

266

1810

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

7.9

1201

10244

C08CA01

ATC

amlodipine; oral

1.2

7.9

1132

9595

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.6

7.9

178

1103

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

7.9

108

574

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.3

7.8

485

3694

M54

ICD-10 Finland

Dorsalgia

1.4

7.8

451

3397

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

7.8

469

3553

M53.2

ICD-10 Finland

Spinal instabilities

3.1

7.8

135

R51.81

ICD-10 Finland

Facial pain NOS

2.0

7.8

497

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

7.8

4699

45340

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

7.8

471

3574

K90.0

ICD-10 Finland

Coeliac disease

1.8

7.8

119

656

ACC51

NOMESCO Finland

Release of median nerve

1.5

7.8

296

2067

SBA00

NOMESCO Finland

Microbiological examinations

2.0

7.7

449

C09CA06

ATC

candesartan; oral

1.3

7.7

835

6855

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

7.7

254

1721

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

3.0

7.7

136

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

7.7

213

1386

DHB50

NOMESCO Finland

Turbinoplasty

1.9

7.7

106

561

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.6

7.7

178

1110

N05CF01

ATC

zopiclone; oral

1.2

7.7

1222

10465

C07AA05

ATC

propranolol; systemic

1.3

7.7

855

7045

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.4

7.7

104

S06.0

ICD-10 Finland

Concussion

1.4

7.7

388

2857

TQX05

NOMESCO Finland

Skin puncture, unspecified location

5.9

7.7

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.9

7.7

106

564

S97

ICPC

Chronic ulcer skin

1.7

7.6

142

833

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

7.6

2502

22864

B01AC04

ATC

clopidogrel; oral

1.4

7.6

383

2820

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.8

7.6

119

661

R4120

NOMESCO Finland

Occupational therapy

1.5

7.6

231

1539

L25.3

ICD-10 Finland

Unspecified contact dermatitis due to other chemical products

25.0

7.6

H04AA01

ATC

glucagon; nasal, parenteral

1.9

7.6

101

530

UKC02

NOMESCO Finland

Cystoscopy

1.4

7.6

443

3346

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.9

7.5

101

531

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

7.5

414

3091

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

7.5

299

2108

B35.1

ICD-10 Finland

Tinea unguium

1.6

7.5

184

1162

K59.0

ICD-10 Finland

Constipation

1.6

7.5

173

1078

J01EA01

ATC

trimethoprim; systemic

1.2

7.5

1101

9351

N06AX11

ATC

mirtazapine; oral

1.2

7.5

1330

11518

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

7.4

433

D01AE15

ATC

terbinafine; topical

1.5

7.4

225

1499

WXQ26

NOMESCO Finland

UVB broad spectrum light therapy

80.2

7.4

L25.0

ICD-10 Finland

Unspecified contact dermatitis due to cosmetics

80.2

7.4

R52.2

ICD-10 Finland

Other chronic pain

1.8

7.4

123

694

B86

ICD-10 Finland

Scabies

2.3

7.4

287

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

7.4

170

1058

C07AB02

ATC

metoprolol; systemic

1.3

7.4

633

5050

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

7.4

444

3366

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

7.4

338

2446

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

7.4

189

1211

L25

ICD-10 Finland

Unspecified contact dermatitis

5.3

7.4

H60.3

ICD-10 Finland

Other infective otitis externa

2.0

7.4

414

K12.18

ICD-10 Finland

Other forms of stomatitis

3.6

7.3

L28

ICD-10 Finland

Lichen simplex chronicus and prurigo

3.6

7.3

L24.2

ICD-10 Finland

Irritant contact dermatitis due to solvents

+∞

7.3

6923B

ICD-9 Finland

Contact dermatitis and other eczema, Due to drugs and medicines in contact with skin[DERMATITIS ARTEFACTA E PHARMACIS ALLERGICA]

+∞

7.3

6925D

ICD-9 Finland

Contact dermatitis and other eczema, Due to food in contact with skin[DERMATITIS ARTEFAC.EX ALIMENTIS ALLERG,VIIVÄSTYNYT]

+∞

7.3

XQ805

NOMESCO Finland

Photopatchtest of photoallergen

+∞

7.3

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.0

7.3

431

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.5

7.3

241

1636

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

7.3

183

1168

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.3

7.2

295

L13

ICPC

Hip symptom/complaint

1.3

7.2

548

4298

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.1

7.2

350

S74

ICPC

Dermatophytosis

2.2

7.2

296

A01

ICPC

Pain general/multiple sites

1.5

7.2

268

1867

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

1.9

7.2

106

575

S01AA02

ATC

chlortetracycline; ophthalmic

3.3

7.2

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.7

7.2

161

R03DA04

ATC

theophylline; systemic, rectal

1.7

7.2

141

843

Z57.3

ICD-10 Finland

Occupational exposure to other air contaminants

4.1

7.2

R31

ICD-10 Finland

Unspecified haematuria

1.5

7.1

238

1619

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

7.1

695

5636

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.4

7.1

241

EMB10

NOMESCO Finland

Tonsillectomy

1.5

7.1

262

1820

H57.1

ICD-10 Finland

Ocular pain

1.7

7.1

128

746

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

7.1

319

2307

A06AD11

ATC

lactulose; oral

1.3

7.1

417

3152

A07EC02

ATC

mesalazine; oral, rectal

1.5

7.0

207

1370

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.9

7.0

517

SPAT1097

SPAT

Recording of ECG

1.3

7.0

488

3782

H25.8

ICD-10 Finland

Other senile cataract

1.5

7.0

264

1844

D01

ICPC

Abdominal pain/cramps general

1.3

7.0

428

3255

D10AX03

ATC

azelaic acid; topical

1.4

7.0

345

2530

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

7.0

258

1794

H70

ICPC

Otitis externa

2.1

7.0

376

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

7.0

370

2747

N76.0

ICD-10 Finland

Acute vaginitis

1.4

7.0

273

1920

Z04.3

ICD-10 Finland

Examination and observation following other accident

2.0

7.0

403

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

6.9

508

3963

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

6.9

668

5407

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

6.9

364

2703

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

6.9

340

2496

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.5

6.9

238

1630

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.6

6.9

160

1000

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

6.9

229

1557

D06BB03

ATC

aciclovir; topical

1.5

6.9

199

1310

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

6.9

255

1773

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

6.9

145

884

EKA10

NOMESCO Finland

Biopsy of cheek

2.0

6.9

385

M01AC06

ATC

meloxicam; systemic, rectal

1.2

6.9

1573

13919

J01DA08

ATC

[U] cefaclor; oral

1.3

6.8

511

4001

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

6.8

310

2241

A10BA02

ATC

metformin; oral

1.2

6.8

868

7257

SPAT1238

SPAT

Brief therapy

1.9

6.8

467

OAA65

SPAT

1.3

6.8

442

3396

XQ806

NOMESCO Finland

Minimal Erythema Dose (MED) test

40.1

6.8

RS340

NOMESCO Finland

5.3

6.8

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.6

6.7

152

944

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

6.7

3420

32206

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.7

6.7

143

875

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

6.7

1662

14797

H01.9

ICD-10 Finland

Inflammation of eyelid, unspecified

2.4

6.7

218

H10

ICD-10 Finland

Conjunctivitis

1.5

6.7

245

1701

XQ845

NOMESCO Finland

Dermatoscopy

2.7

6.6

161

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.0

6.6

386

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

6.6

295

2130

L43.3

ICD-10 Finland

Subacute (active) lichen planus

5.9

6.6

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

6.6

247

1724

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

6.6

667

5434

M54.2

ICD-10 Finland

Cervicalgia

1.4

6.6

275

1963

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

6.6

209

1411

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

1.8

6.6

546

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

6.5

702

5754

L02

ICPC

Back symptom/complaint

1.4

6.5

358

2676

J01DA06

ATC

[U] cefuroxime; systemic

1.3

6.5

601

4837

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

6.5

307

2236

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

6.5

154

967

R03CC02

ATC

salbutamol; systemic

1.5

6.5

234

1623

D07XB02

ATC

triamcinolone, combinations; topical

2.3

6.5

259

D82

ICPC

Teeth/gum disease

1.2

6.4

1580

14043

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

6.4

302

2201

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

6.4

319

2344

SPAT1014

SPAT

Treatment of eyes

2.3

6.4

249

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

2.3

6.4

241

D01AC03

ATC

econazole; topical

1.5

6.4

201

1352

A07EA06

ATC

budesonide; oral, local oral

1.7

6.4

125

748

EBA10

NOMESCO Finland

Surgical removal of tooth

1.3

6.4

508

4015

XCK00

NOMESCO Finland

Perimetry

1.5

6.4

211

1436

G50.1

ICD-10 Finland

Atypical facial pain

2.0

6.4

379

G03DA02

ATC

medroxyprogesterone; systemic (pregnen (4) derivatives)

1.4

6.4

358

2689

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

6.4

758

6292

W19

ICD-10 Finland

Unspecified fall

1.4

6.3

314

2306

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

6.3

248

1744

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.1

6.3

297

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.5

6.3

194

1298

D06

ICPC

Abdominal pain localized other

1.4

6.3

315

2319

F03

ICPC

Eye discharge

1.4

6.3

242

1698

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

6.3

229

1588

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

6.3

256

1816

L29.2

ICD-10 Finland

Pruritus vulvae

2.6

6.3

169

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

5.9

6.3

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

6.3

160

1027

J01

ICD-10 Finland

Acute sinusitis

1.5

6.3

207

1409

M67.4

ICD-10 Finland

Ganglion

1.4

6.3

254

1799

M54.8

ICD-10 Finland

Other dorsalgia

1.6

6.3

158

1009

L13.0

ICD-10 Finland

Dermatitis herpetiformis

4.6

6.3

XQ812

NOMESCO Finland

Contact urticaria assay

18.0

6.3

6931A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to food

+∞

6.2

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.9

6.2

430

E03

ICD-10 Finland

Other hypothyroidism

1.5

6.2

221

1528

N30.0

ICD-10 Finland

Acute cystitis

1.3

6.2

548

4387

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

2.6

6.2

164

L10

ICPC

Elbow symptom/complaint

1.6

6.2

167

1086

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

2.5

6.2

174

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

6.2

191

1281

C10AA07

ATC

rosuvastatin; oral

1.2

6.2

791

6614

B00.10

ICD-10 Finland

Herpes simplex facialis

2.8

6.2

128

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

6.1

269

1933

C05AA01

ATC

hydrocortisone; rectal, topical

1.5

6.1

180

1193

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.2

6.1

1127

9767

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.6

6.1

147

928

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.4

6.1

251

1786

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

3.3

6.1

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

6.1

559

Z00.8

ICD-10 Finland

Other general examinations

1.4

6.1

255

1820

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.8

6.1

514

H02AB09

ATC

hydrocortisone; systemic

1.9

6.1

455

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.5

6.1

175

1155

Z3226

NOMESCO Finland

Physiotherapist

1.2

6.1

695

5737

SPAT1255

SPAT

Intravenous administration of medicine

1.5

6.1

205

1403

K13.29

ICD-10 Finland

Indefinite leukoplakia

2.6

6.1

160

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

2.0

6.1

373

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.5

6.1

185

1236

R32

ICD-10 Finland

Unspecified urinary incontinence

1.8

6.1

533

C10AC01

ATC

colestyramine; oral

1.8

6.0

523

WZA90

NOMESCO Finland

Other doctors statement

1.2

6.0

959

8199

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

1062

3085

3.96

318.07

1.4

1.3

u/ml

341.9

130.7

8.84

994

2839

(40768443) Skin Pathology biopsy report

509

1588

3.41

132.16

1.3

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

118

12.78

121.43

1.3

1.4

titre

35.6

65.0

—

(3000494) Fungus identified in Specimen by Culture

1019

5244

2.13

94.74

1.6

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

112

120

9.49

94.31

1.4

u/ml

20.4

23.6

0.25

(3018010) Neutrophils/100 leukocytes in Blood

3171

23462

1.73

93.17

6.3

5.7

56.2

56.6

0.98

3001

21972

(3019069) Monocytes/100 leukocytes in Blood

3121

22993

1.73

93.12

6.8

6.1

8.2

8.3

0.50

2951

21561

(3013115) Eosinophils [#/volume] in Blood

3363

25319

1.73

92.52

6.4

5.9

e9/l

0.2

13.81

3032

22347

(3002030) Lymphocytes/100 leukocytes in Blood

3200

23809

1.72

91.48

6.6

5.9

29.1

0.08

3019

22210

(3006504) Eosinophils/100 leukocytes in Blood

3100

22877

1.72

91.20

6.5

5.8

3.1

2.8

10.53

2916

21304

(3022096) Basophils/100 leukocytes in Blood

3005

22130

1.70

87.85

6.6

5.9

0.7

0.75

2818

20617

(3006315) Basophils [#/volume] in Blood

3224

24421

1.68

82.86

6.3

5.7

e9/l

0.0

3.56

2888

21149

(3001604) Monocytes [#/volume] in Blood

3213

24332

1.68

82.51

6.2

5.7

e9/l

0.6

4.56

2891

21095

(3013707) Erythrocyte sedimentation rate by Westergren method

4487

37194

1.78

82.10

4.5

3.8

mm/h

11.2

11.0

0.53

4171

34703

(3019198) Lymphocytes [#/volume] in Blood

3298

25185

1.67

81.67

6.3

5.7

e9/l

2.0

0.61

2999

22311

(1761482) Bacteria [#/volume] in Urine by Culture

310

975

3.30

78.77

4.4

4.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

137

231

6.04

77.60

1.2

1.5

ug/l

5.2

8.5

2.54

125

200

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

17.67

77.45

1.0

u/ml

0.1

0.0

0.84

(3027231) Wheat IgE Ab [Units/volume] in Serum

11.98

76.35

1.1

1.0

u/ml

2.7

—

(42870588) Differential panel, method unspecified - Blood

2267

15985

1.66

74.24

6.2

5.9

—

(3037522) Nuclear Ab [Titer] in Serum

1207

7143

1.86

73.29

1.5

1.3

titre

564.0

566.3

0.01

228

1447

(3013512) EKG study

1867

12556

1.70

72.89

4.1

3.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

939

5228

1.94

68.32

2.0

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1797

12142

1.68

67.98

1.4

1.3

u/ml

2.0

1.5

0.85

435

3402

(3003888) Timothy IgE Ab [Units/volume] in Serum

293

973

3.11

67.92

1.1

u/ml

6.2

5.0

0.51

162

468

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

10.86

66.97

1.1

1.0

u/ml

2.4

0.1

0.72

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

15.41

63.11

1.0

u/ml

0.0

0.53

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

14.60

61.30

1.0

u/ml

0.3

0.0

0.60

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

16.80

59.95

1.0

u/ml

0.1

1.0

0.42

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

302

1111

2.81

58.19

1.1

u/ml

1.7

0.9

0.52

140

388

(3013650) Neutrophils [#/volume] in Blood by Automated count

3487

28375

1.53

55.88

8.1

8.9

e9/l

4.0

0.54

3129

24819

(3012494) Peanut IgE Ab [Units/volume] in Serum

127

6.77

54.19

1.1

u/ml

1.6

2.7

0.28

(3011841) English Walnut IgE Ab [Units/volume] in Serum

14.11

53.59

1.0

u/ml

3.3

0.0

0.51

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

938

5614

1.79

53.22

4.4

4.1

31.8

32.5

1.14

685

3924

(3008401) Mugwort IgE Ab [Units/volume] in Serum

259

930

2.86

52.18

1.1

u/ml

2.1

0.8

0.97

130

348

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4335

37336

1.55

50.80

7.3

7.0

u/l

75.5

76.0

0.33

4085

35176

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

153

5.96

50.59

1.1

1.0

u/ml

8.8

4.8

0.66

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

13.07

50.24

1.0

u/ml

0.8

0.0

1.48

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2001

14696

1.54

50.04

2.6

2.4

u/l

58.4

57.3

0.24

1831

13554

(3007164) IgA [Mass/volume] in Serum or Plasma

1502

10358

1.60

49.48

1.4

g/l

2.4

2.2

1.62

903

6446

(3038515) Glucose [Moles/volume] in Venous blood

219

740

3.03

49.20

3.4

2.9

mmol/l

7.2

7.3

0.34

219

720

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4693

41380

1.58

47.35

4.7

4.2

pmol/l

14.6

0.05

4310

38241

(3008037) Lactate [Moles/volume] in Venous blood

224

788

2.91

46.84

3.3

2.8

mmol/l

1.5

0.35

224

767

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

12.24

45.28

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

728

4268

1.80

43.69

1.2

—

(3000330) Specific gravity of Urine by Test strip

445

2229

2.07

42.75

4.4

3.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1366

9492

1.57

42.57

1.3

iu/ml

27.6

31.8

0.48

408

3011

(3010726) Horse dander IgE Ab [Units/volume] in Serum

236

913

2.65

41.19

1.1

u/ml

2.3

1.2

0.83

198

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

14.31

40.76

1.0

u/ml

0.6

0.0

0.82

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5248

47997

1.66

40.60

5.6

4.8

mu/l

1.8

2.0

2.11

4857

44738

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

296

1284

2.37

40.50

1.2

1.3

u/ml

5.3

5.4

0.01

131

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

299

1304

2.36

40.42

1.2

1.3

u/ml

7.2

7.3

0.01

219

(3037467) Urinalysis macro (dipstick) panel - Urine

3986

34487

1.45

39.26

4.7

4.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2104

16214

1.45

39.09

3.5

3.1

ng/l

68.5

77.3

0.07

1223

9463

(3048689) Calprotectin [Mass/mass] in Stool

1023

6761

1.62

39.07

2.4

2.3

ug/g

135.7

112.5

0.99

784

5303

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5520

51339

1.78

38.11

14.6

11.7

mg/l

18.4

21.2

9.41

4485

39746

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1291

9088

1.53

37.25

1.3

u/ml

7.8

11.9

1.87

536

3764

(3019225) pH of Specimen

714

4357

1.72

36.94

3.8

3.9

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

312

1444

2.22

36.64

1.2

1.3

u/ml

32.1

43.7

0.27

100

(3004616) Nuclear Ab [Presence] in Serum

167

575

2.96

36.33

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2949

24451

1.40

35.10

5.1

5.8

umol/l

9.6

10.5

8.33

2764

23116

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2293

18218

1.41

34.95

2.0

1.9

pmol/l

100.4

97.9

1.48

1182

9296

(3020874) Milk IgE Ab [Units/volume] in Serum

114

318

3.63

34.92

1.1

1.0

u/ml

6.2

0.7

0.58

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4018

35259

1.41

33.34

3.4

2.9

u/l

43.9

41.3

1.10

3767

33268

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

295

1387

2.18

33.31

1.5

1.7

g/l

0.2

0.69

278

1318

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

239

1032

2.37

33.04

1.2

1.3

u/ml

3.4

2.8

0.11

(3013826) Glucose [Moles/volume] in Serum or Plasma

3228

27332

1.38

33.02

4.4

4.2

mmol/l

6.6

6.5

0.29

2974

25198

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1538

11505

1.45

32.11

1.7

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

390

2062

1.95

32.04

1.3

u/ml

1.5

1.0

0.26

179

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

20.07

31.05

1.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

297

1440

2.12

31.00

1.5

1.7

g/l

1.2

0.15

280

1368

(3019550) Sodium [Moles/volume] in Serum or Plasma

5481

51362

1.65

30.54

14.8

12.7

mmol/l

139.6

139.7

3.02

5340

50057

(3018001) Oat IgE Ab [Units/volume] in Serum

11.09

30.21

1.0

u/ml

0.2

0.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

11.53

30.02

1.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5491

51546

1.65

29.56

15.0

12.8

mmol/l

3.9

0.29

5340

50131

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2707

22547

1.36

29.27

6.1

mmol/l

1.2

1.31

2278

19018

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

311

1578

2.02

28.71

1.1

u/ml

12.2

6.0

0.28

226

(3027273) Bicarbonate [Moles/volume] in Venous blood

332

1732

1.97

28.33

3.5

3.1

mmol/l

25.7

25.4

1.47

326

1674

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

305

1549

2.02

28.09

1.7

1.9

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

7.23

27.94

1.1

1.2

u/ml

0.0

0.08

(3032080) INR in Blood by Coagulation assay

2099

16909

1.37

27.60

7.2

7.4

inr

1.1

1.2

0.93

552

5181

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1693

13192

1.39

27.25

2.2

2.0

u/l

163.3

192.6

0.92

1599

12411

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2542

21164

1.34

26.71

2.5

2.2

nmol/l

77.4

76.6

0.74

2277

19393

(4010399)

530

3267

1.68

26.05

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

367

2040

1.85

25.82

1.6

1.7

—

(44813793)

114

385

3.00

25.76

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

123

4.75

25.65

1.4

1.5

ug/l

9.6

8.4

1.13

123

(3036481) Cortisol [Moles/volume] in Serum or Plasma

694

4611

1.57

25.12

2.0

2.1

nmol/l

370.2

374.3

0.17

632

4236

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5205

48605

1.48

25.08

4.5

4.0

mmol/l

5.8

1.38

4771

44946

(3033705) Calcium.ionized [Moles/volume] in Venous blood

120

424

2.87

25.01

2.6

2.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1448

11157

1.39

24.45

1.9

1.7

mg/l

0.9

1.0

0.98

1092

8468

(3007700) Barley IgE Ab [Units/volume] in Serum

10.88

24.21

1.0

u/ml

1.0

0.0

—

(3035285) Chloride [Moles/volume] in Venous blood

120

432

2.81

24.18

2.6

2.2

mmol/l

106.0

105.4

0.69

120

427

(3041354) Potassium [Moles/volume] in Venous blood

120

432

2.81

24.18

2.6

2.2

mmol/l

4.0

0.18

120

427

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

6.89

24.15

1.1

1.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4876

45066

1.41

24.15

5.9

5.0

mmol/mol

39.3

38.7

4.73

4513

42174

(3014599) Egg white IgE Ab [Units/volume] in Serum

322

3.11

23.89

1.1

1.0

u/ml

5.8

0.4

1.50

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

12.82

23.71

1.0

1.1

u/ml

0.2

0.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

106

364

2.95

23.29

1.3

u/ml

1.3

1.1

0.07

160

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5104

47665

1.43

22.86

12.2

10.7

ml/min/173m2

86.1

85.7

0.76

4289

39116

(3007542) Rye IgE Ab [Units/volume] in Serum

10.46

22.66

1.0

u/ml

0.5

0.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1470

11507

1.37

22.17

2.2

mg/l

2.8

0.71

1281

9887

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2024

16628

1.32

22.06

3.1

u/l

29.5

33.3

2.03

1921

15842

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

223

1108

2.05

21.84

1.5

iu/ml

31.3

17.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

176

803

2.23

21.47

1.1

u/ml

6.7

2.3

1.72

268

(3025468) Yersinia sp identified in Specimen by Organism specific culture

139

573

2.46

21.39

1.5

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1500

11838

1.35

21.33

2.3

umol/l

6377.8

3984.3

1.13

1313

10420

(3005988) Vibrio sp identified in Specimen by Organism specific culture

139

577

2.44

21.07

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

139

577

2.44

21.07

1.5

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5300

50026

1.45

20.66

4.5

3.9

mmol/l

1.5

0.95

4916

46820

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5325

50310

1.46

20.61

4.6

4.0

mmol/l

4.8

0.69

4973

47265

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

271

3.13

20.61

1.1

u/ml

17.3

7.5

0.71

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

138

579

2.42

20.45

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

140

593

2.39

20.32

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

138

581

2.41

20.30

1.5

1.4

—

(3015736) pH of Urine

2242

18898

1.29

19.60

3.4

3.2

—

5.9

—

(3011897) Casein IgE Ab [Units/volume] in Serum

5.86

19.60

1.2

1.0

u/ml

24.2

0.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5124

48169

1.40

19.57

4.2

3.6

mmol/l

1.3

1.32

4738

44853

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

262

1431

1.87

19.50

1.6

titre

224.0

417.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1350

10613

1.35

19.40

2.9

2.8

ng/l

902.7

1051.7

1.07

1104

8912

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2772

24036

1.28

19.30

3.0

2.8

ug/l

97.9

98.4

0.02

2588

22510

(3041096) Erythrocytes [Presence] in Urine by Automated

1707

13893

1.32

19.30

3.6

3.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1006

7553

1.40

19.26

1.7

nmol/l

1067.1

1175.1

3.53

750

5809

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

219

1133

1.97

19.19

1.2

1.3

u/ml

60.1

38.2

0.68

117

(40768797) Stomach Pathology biopsy report

902

6658

1.42

19.03

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5374

51000

1.45

18.94

4.9

4.4

mmol/l

2.9

0.70

4969

47593

(3042936) Bacteria identified in Isolate by Culture

844

6169

1.43

18.80

2.2

1.9

—

(3023368) Bacteria identified in Blood by Culture

1364

10790

1.34

18.71

4.2

4.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

11.91

18.68

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5683

54578

1.59

18.67

11.2

9.3

u/l

25.7

25.4

0.43

5518

52852

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

375

2301

1.67

18.67

3.4

3.7

mmol/l

1.6

1.8

0.30

268

1698

(3002032) Base excess in Venous blood by calculation

523

3481

1.55

18.59

4.3

3.9

mmol/l

1.7

1.9

0.75

429

2829

(3021960) Folate [Moles/volume] in Serum or Plasma

1266

9932

1.35

18.30

1.5

nmol/l

20.3

21.0

0.94

1065

8583

(3026782) Osmolality of Urine

1127

8685

1.36

18.30

3.0

2.6

mosm/kgh2o

554.8

532.8

2.32

974

7392

(40761511) CBC panel - Blood by Automated count

5646

54174

1.56

18.24

13.8

11.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1556

12582

1.32

18.24

4.3

3.9

mg/mmol

9.1

8.3

0.27

954

7775

(3013139) Helicobacter pylori Ag [Presence] in Stool

528

3537

1.54

18.22

1.3

1.2

—

(3009343) pH of Capillary blood

384

2389

1.65

18.12

3.4

3.7

7.4

0.30

319

(3021447) Carbon dioxide [Partial pressure] in Venous blood

521

3497

1.54

17.81

4.3

3.9

kpa

5.8

0.79

507

3393

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

164

3.56

17.58

1.1

1.2

g/l

0.3

0.16

127

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

385

2425

1.63

17.29

3.4

3.7

kpa

5.2

5.1

0.03

345

2255

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

267

1523

1.79

17.28

3.5

3.9

mmol/l

24.7

24.9

0.56

246

1422

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

533

3621

1.52

17.21

2.5

2.4

au/ml

17.1

27.0

1.54

248

(3022313) Gas panel - Capillary blood

296

1744

1.73

17.12

3.3

3.8

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

140

643

2.20

16.88

1.2

1.3

u/ml

43.8

65.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

440

2879

1.57

16.84

3.6

3.3

kpa

4.5

4.6

1.25

427

2784

(3017181) Myelocytes/100 leukocytes in Blood

563

3892

1.49

16.70

3.8

4.0

0.8

0.9

0.25

137

984

(3017732) Neutrophils [#/volume] in Blood

526

3592

1.51

16.56

2.6

e9/l

4.0

4.1

0.37

395

2914

(3021589) Normoblasts [#/volume] in Blood

2538

22039

1.26

16.53

9.5

8.6

e9/l

0.0

0.86

2106

18014

(3021440) Promyelocytes/100 leukocytes in Blood

541

3720

1.50

16.47

3.9

4.1

0.1

0.26

128

908

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

329

2023

1.66

16.25

1.9

2.0

u/l

39.4

39.5

0.04

297

1834

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

492

3327

1.52

16.22

1.4

1.3

au/ml

58.3

46.6

0.27

145

(3023430) Cat dander IgE Ab [Units/volume] in Serum

155

754

2.08

16.16

1.1

u/ml

6.2

3.0

1.24

267

(3022948) Iron [Moles/volume] in Serum or Plasma

909

6906

1.37

15.94

2.2

2.3

umol/l

13.8

13.7

0.08

839

6415

(3000492) Spirometry study

677

4906

1.43

15.67

1.5

1.4

—

(3022145) Colonoscopy Study observation

727

5343

1.41

15.54

1.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2352

20351

1.25

15.47

5.4

mmol/l

1.2

2.05

2065

18480

(3031040) Bacteria [#/volume] in Urine by Automated count

3626

32955

1.25

15.20

4.6

4.0

e6/l

184.1

1781.1

4.34

392

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

223

1254

1.81

15.17

1.9

2.1

mg/l

9.9

10.5

0.60

203

1165

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

115

512

2.27

14.99

1.1

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

190

1024

1.88

14.81

1.5

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

294

1805

1.66

14.63

1.8

1.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

511

3558

1.48

14.59

3.8

0.6

0.10

101

724

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

167

877

1.93

14.10

2.3

2.1

nmol/l

0.8

0.12

134

757

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

113

515

2.22

13.96

2.5

2.1

mg/l

25.7

25.1

0.04

135

(40760892) CBC W Ordered Manual Differential panel - Blood

1399

11498

1.28

13.87

4.7

4.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

822

6282

1.36

13.75

2.2

2.3

g/l

2.4

1.37

756

5827

(3025159) Blasts/100 leukocytes in Blood

505

3556

1.46

13.60

3.9

4.1

0.0

0.1

0.74

108

781

(3020630) Protein [Mass/volume] in Serum or Plasma

452

3115

1.49

13.58

2.1

2.6

g/l

67.5

66.7

1.59

410

2865

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

132

654

2.04

13.18

1.1

1.0

u/ml

0.5

0.1

1.33

108

(3007461) Platelets [#/volume] in Blood

5919

57829

1.76

13.17

21.3

17.5

e9/l

265.7

260.1

9.79

5813

56524

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1203

9759

1.29

13.13

1.7

1.6

pmol/l

37168569.5

33926845.7

0.06

1017

8262

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

436

3010

1.48

12.98

1.1

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

259

1590

1.66

12.92

4.0

4.6

0.8

0.9

2.97

253

1474

(3000963) Hemoglobin [Mass/volume] in Blood

5923

57896

1.76

12.91

21.4

17.5

g/l

134.9

134.6

0.87

5853

57211

(3024731) MCV [Entitic volume]

5921

57871

1.75

12.91

21.2

17.4

90.6

0.36

5853

57198

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

343

2.44

12.87

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

2766

24673

1.22

12.86

3.7

3.4

estimate

0.0

1.08

481

4627

(3026361) Erythrocytes [#/volume] in Blood

5921

57878

1.75

12.81

21.3

17.4

e12/l

4.5

0.01

5802

56449

(3035941) MCH [Entitic mass]

5920

57867

1.74

12.79

21.2

17.4

30.2

0.83

5852

57191

(3020961) Endomysium IgA Ab [Titer] in Serum

386

2609

1.51

12.74

1.2

1.1

titre

236.0

179.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2205

19232

1.23

12.74

4.0

3.5

—

(3012516) Albumin [Mass/volume] in Urine

1442

12006

1.26

12.68

3.3

3.2

mg/l

568.6

398.2

0.50

847

7320

(3010813) Leukocytes [#/volume] in Blood

5921

57890

1.74

12.63

21.4

17.5

e9/l

6.8

6.6

6.32

5808

56435

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

259

1608

1.64

12.37

4.0

4.5

1.6

1.7

0.41

252

1487

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

6.80

12.29

1.0

u/ml

5.8

2.0

1.24

(3021601) Nitrite [Presence] in Urine by Test strip

2770

24789

1.21

12.24

5.5

4.6

estimate

0.0

1.34

499

4743

(3024561) Albumin [Mass/volume] in Serum or Plasma

2230

19536

1.22

12.19

4.9

4.5

g/l

36.1

0.28

2063

18162

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

258

1611

1.63

12.05

1.4

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

2792

25034

1.21

12.01

3.8

3.4

estimate

0.0

0.21

489

4671

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

749

5760

1.34

11.94

2.3

2.4

23.1

23.2

0.11

640

4946

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

194

1127

1.75

11.89

1.4

1.3

u/l

27.3

28.6

0.22

155

942

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

250

1557

1.63

11.81

1.7

1.6

iu/ml

3.5

0.1

0.79

340

(40768804) Tissue Pathology biopsy report

2409

21315

1.21

11.81

2.1

2.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

326

2164

1.54

11.72

2.7

2.5

e6/l

0.2

0.3

0.37

320

2082

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

258

2.58

11.54

2.0

1.8

—

(3009508) Creatinine [Moles/volume] in Urine

1587

13494

1.24

11.38

3.1

3.2

mmol/l

7.5

7.4

0.16

1310

11447

(3026008) Bacteria identified in Urine by Culture

1680

14372

1.23

11.38

3.1

2.8

—

(3051101) Glucose [Moles/volume] in Cord blood

4.50

10.93

3.3

6.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

338

2318

1.48

10.43

2.5

2.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

147

821

1.81

10.35

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

426

3062

1.42

10.26

1.7

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

488

3603

1.39

10.06

2.5

2.7

g/l

10.2

10.5

0.82

453

3308

(3037121) Protein [Mass/volume] in Urine

234

1513

1.57

9.52

3.0

3.2

g/l

0.3

0.01

592

(3026389) Candida sp identified in Specimen by Organism specific culture

136

765

1.80

9.39

1.5

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

137

773

1.79

9.37

1.1

iu/ml

178.5

13910.7

0.63

193

(3004588) Protein electrophoresis panel - Serum or Plasma

355

2516

1.44

9.26

1.8

2.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

872

7074

1.27

9.24

3.2

3.4

mmol/l

0.8

0.26

794

6628

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

246

1622

1.54

9.19

2.0

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

142

817

1.76

9.10

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

153

2.82

9.09

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

564

4327

1.33

9.08

1.2

iu/ml

128.0

157.6

1.10

197

1693

(3008898) HLA-B27 [Presence]

308

2138

1.46

8.97

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

311

2164

1.46

8.95

1.1

u/ml

1.8

3.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

207

1329

1.58

8.71

1.4

2.4

g/l

10.4

10.2

0.25

175

1133

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

814

6597

1.27

8.67

1.9

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

262

1774

1.50

8.66

2.2

1.9

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

294

2.22

8.35

1.1

1.0

u/ml

0.8

0.3

0.40

(44806420)

3.31

8.32

2.2

2.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

880

7235

1.25

8.28

2.2

2.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3985

37523

1.18

8.25

3.6

3.3

—

(3016031) Almond IgE Ab [Units/volume] in Serum

5.34

8.20

1.1

1.0

u/ml

0.1

0.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

132

769

1.73

8.14

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

156

952

1.66

8.11

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.14

7.93

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

3.14

7.93

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.14

7.93

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.14

7.93

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

222

1483

1.52

7.86

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

216

1441

1.52

7.70

1.4

2.3

g/l

4.0

3.7

1.35

142

1029

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

216

1442

1.52

7.68

1.4

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

216

1443

1.52

7.65

1.4

2.3

g/l

7.5

7.4

0.42

146

1089

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

403

3019

1.36

7.62

2.4

2.2

u/l

5138.8

5707.0

0.16

145

1238

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

102

3.05

7.56

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

206

2.39

7.48

1.0

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

437

3332

1.34

7.36

3.7

3.5

ng/l

84.9

81.5

0.23

363

2893

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

671

5427

1.27

7.24

2.1

2.6

umol/l

7.5

7.2

0.13

565

4639

(3028026) IgM [Mass/volume] in Serum or Plasma

373

2787

1.36

7.18

1.7

1.9

g/l

1.4

1.3

0.34

347

2566

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

144

901

1.61

6.84

1.1

au/ml

12.0

10.7

0.08

(3051387) C reactive protein [Mass/volume] in Capillary blood

158

1013

1.57

6.78

3.5

3.3

mg/l

22.8

25.6

0.52

100

620

(3009542) Hematocrit [Volume Fraction] of Blood

5019

48477

1.20

6.63

14.8

12.7

38.9

39.7

6.61

3677

37450

(3002582) Erythrocytes [#/volume] in Urine

1542

13653

1.17

6.55

3.1

2.9

e6/l

38.5

86.5

2.51

1201

10260

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2605

23987

1.15

6.54

3.9

3.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.65

6.46

1.1

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

335

1.98

6.38

1.5

2.7

e6/l

547.1

502.8

0.37

280

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

244

1738

1.42

6.29

2.9

0.7

1.32

238

1672

(3018095) Leukocytes [#/volume] in Urine

1850

16660

1.16

6.26

3.5

3.4

e6/l

92.3

96.6

0.07

1292

11249

(3011412) CD3 cells [#/volume] in Blood

464

1.80

6.01

1.6

2.5

e9/l

1.2

0.13

283

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

392

1.87

6.00

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

218

1537

1.43

5.97

1.5

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

1742

15664

1.16

5.96

2.4

2.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

323

1.96

5.95

1.6

2.8

e9/l

0.2

0.12

277

(3045683) HLA typing for celiac disease panel - Blood or Tissue

331

1.94

5.89

1.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

169

1137

1.50

5.88

1.4

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

190

1309

1.47

5.88

1.3

1.4

ug/g

304.5

293.2

0.30

102

722

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

191

2.26

5.88

1.5

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

191

2.26

5.88

1.5

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1334

11769

1.17

5.84

2.0

1.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

785

6611

1.22

5.82

1.7

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

762

6406

1.22

5.75

1.5

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

653

5411

1.23

5.67

5.9

5.4

mmol/l

1.1

1.0

0.47

593

5036

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.06

5.62

1.6

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

939

8069

1.19

5.61

2.3

2.1

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

12.87

5.57

1.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

550

4482

1.25

5.57

3.7

4.2

u/l

230.1

241.4

1.14

518

4242

(3034274) Bile acid [Moles/volume] in Serum --fasting

139

909

1.54

5.55

1.6

2.2

umol/l

4.6

5.3

0.71

658

(40758558) Short blood count panel - Blood

1394

12390

1.16

5.51

6.3

6.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1327

11759

1.16

5.45

2.3

2.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

244

2.06

5.44

1.5

1.3

—

(4062490)

496

1.72

5.36

1.4

—

(4024509)

468

1.74

5.29

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

240

2.05

5.29

1.5

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1438

12859

1.15

5.20

1.7

1.6

mmol/l

1.4

0.33

1248

10923

(3015377) Calcium [Moles/volume] in Serum or Plasma

1751

15892

1.14

5.11

3.0

3.3

mmol/l

2.4

0.73

1464

14057

(3030467) Casts [#/volume] in Urine by Automated count

1401

12522

1.15

5.09

3.1

2.9

e6/l

0.2

0.4

4.47

1063

9270

(3045424) Erythrocytes [Presence] in Urine

128

840

1.54

5.06

1.3

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

111

708

1.58

4.98

1.2

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

112

2.51

4.86

1.4

1.7

ug/l

0.3

0.4

0.75

(3024139) IgG subclass 3 [Mass/volume] in Serum

503

1.68

4.86

1.3

1.4

g/l

0.4

0.56

352

(3028192) IgG subclass 2 [Mass/volume] in Serum

503

1.68

4.86

1.3

1.4

g/l

2.9

0.06

353

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

107

2.53

4.78

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

500

1.67

4.71

1.4

mmol/l

11.1

11.4

0.07

(3000475) Leukocytes [#/volume] in Synovial fluid

146

1003

1.47

4.67

1.6

e6/l

11656.6

10952.4

0.11

105

737

(3032057) Clostridioides difficile [Presence] in Stool

2.71

4.67

1.8

1.9

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

503

1.66

4.61

1.3

1.4

g/l

6.0

6.8

1.88

352

(3024980) IgG subclass 4 [Mass/volume] in Serum

120

795

1.52

4.58

1.4

1.6

g/l

0.7

0.08

603

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

170

1210

1.42

4.51

2.5

2.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

639

5407

1.20

4.51

5.1

5.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

512

4242

1.23

4.48

2.0

2.6

1.7

1.8

0.63

443

3785

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1123

9962

1.16

4.48

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

192

1404

1.38

4.36

2.1

1.9

ug/l

1.3

2.1

1.09

172

1253

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

107

2.44

4.29

1.1

1.2

101.6

94.5

0.56

107

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

864

7538

1.17

4.28

2.8

2.5

e6/l

1.1

1.2

0.28

525

4141

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

198

2.03

4.26

1.1

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

313

2468

1.28

4.24

1.5

—

(3025941) Bacteria identified in Stool by Culture

380

3068

1.25

4.23

1.3

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

2.99

4.11

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.99

4.11

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

141

2.20

4.10

1.5

3.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

179

1309

1.38

4.09

2.6

2.2

ug/l

275.1

591.0

1.10

165

1205

(3014576) Chloride [Moles/volume] in Serum or Plasma

588

4987

1.20

4.06

6.9

6.7

mmol/l

104.5

104.6

0.16

583

4890

(3006270) Folate [Moles/volume] in Blood

383

1.70

4.05

1.1

nmol/l

351.3

397.8

1.04

353

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

451

3736

1.22

3.98

3.3

3.5

mmol/l

1.2

1.27

395

3271

(3028679) Herpes simplex virus Ab [Presence] in Serum

296

1.80

3.98

1.1

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

184

1361

1.36

3.93

1.4

2.4

g/l

3.1

0.02

144

1059

(3035947) Staphylolysin Ab [Units/volume] in Serum

185

2.01

3.87

1.1

iu/ml

2.8

3.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

7.28

3.85

1.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

741

6442

1.17

3.84

2.3

2.1

29.5

0.06

720

6259

(3023520) Reticulocytes [#/volume] in Blood

378

3086

1.24

3.84

2.0

2.6

e9/l

69.1

70.2

0.27

282

2293

(3020779) Urea [Moles/volume] in Serum or Plasma

405

3337

1.23

3.78

8.1

7.3

mmol/l

8.8

8.7

0.05

384

3198

(3037756) Immunofixation for Serum or Plasma

103

692

1.50

3.75

1.4

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

440

1.62

3.69

2.8

3.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.25

3.62

1.1

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

284

1.77

3.58

1.2

1.5

u/l

5.1

6.3

1.03

244

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

329

1.71

3.57

1.6

2.8

e6/l

824.8

794.6

0.13

135

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

291

2328

1.26

3.55

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

153

1119

1.38

3.55

1.4

2.3

g/l

37.5

38.1

0.47

133

977

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.81

3.52

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

346

1.68

3.51

1.7

2.1

u/field

1.1

2.0

0.98

145

(3025018) Bordetella pertussis Ab [Titer] in Serum

339

1.69

3.49

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

521

4438

1.19

3.46

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

485

4109

1.20

3.42

2.4

2.2

g/l

0.2

1.18

450

3866

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

349

1.67

3.41

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

349

1.67

3.41

3.7

3.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

118

832

1.43

3.40

1.4

mmol/l

6.5

7.1

1.09

618

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

795

7016

1.15

3.39

2.9

2.7

e6/l

3.6

3.4

0.30

467

3647

(3034770) Mitochondria Ab [Titer] in Serum

183

1387

1.33

3.39

1.3

titre

1755.0

1046.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

342

1.67

3.39

1.5

2.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

135

978

1.39

3.34

3.3

3.5

55.6

56.9

0.72

135

978

(3049717) Cytology report of Urine Cyto stain

166

1244

1.34

3.32

2.2

2.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

183

1394

1.32

3.28

1.3

titre

91.4

108.0

0.28

138

(3044290) Cell count panel - Cerebral spinal fluid

140

1024

1.38

3.27

1.3

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.50

3.20

4.5

6.6

—

(4094501)

163

1226

1.34

3.20

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

120

861

1.40

3.16

1.1

u/ml

3.6

0.00

455

(3011985) Renin [Units/volume] in Plasma

621

1.47

3.14

1.7

1.5

mu/l

89.9

53.7

0.78

556

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

136

998

1.37

3.13

1.4

2.4

g/l

0.0

0.46

126

925

(3003181) Sodium [Moles/volume] in Urine

663

1.46

3.12

1.5

1.4

mmol/l

63.6

65.3

0.13

528

(4146454)

413

1.58

3.11

4.0

2.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

390

1.60

3.09

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

390

1.60

3.09

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

390

1.60

3.09

1.2

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.24

3.05

1.0

—

(3044927) Protein electrophoresis panel - Urine

376

1.60

3.05

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

153

1.97

3.03

2.6

2.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

134

988

1.36

3.01

1.4

2.4

g/l

0.0

0.00

124

923

(3015235) Bicarbonate [Moles/volume] in Capillary blood

130

954

1.37

3.01

3.1

3.4

mmol/l

24.9

0.04

113

831

(40760888) Immunoglobulin light chains.free panel - Serum

113

810

1.40

3.01

2.2

3.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

113

2.13

2.99

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

347

1.62

2.98

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.24

2.95

1.7

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

434

3693

1.19

2.95

3.2

3.4

pmol/l

4.5

0.38

370

3330

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

169

1.90

2.94

1.0

1.1

107.4

93.3

1.11

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

396

1.57

2.92

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

396

1.57

2.92

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

396

1.57

2.92

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

357

1.60

2.91

1.1

ratio

1.0

1.1

0.22

121

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.34

2.90

1.1

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

350

1.61

2.89

1.1

1.2

—

(3004775) Volume in Urine collected for unspecified duration

296

1.66

2.89

2.2

2.3

645.2

602.2

0.34

205

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

178

1.86

2.85

1.3

1.1

ng/l

801.2

308.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

276

2257

1.23

2.84

1.4

1.3

miu/ml

211.5

235.7

0.54

134

1110

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

146

1102

1.33

2.84

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.06

2.80

2.2

2.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

142

1070

1.33

2.80

2.2

3.5

ratio

1.3

2.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

223

1785

1.26

2.79

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.92

2.77

1.1

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

614

1.44

2.75

1.1

1.2

nmol/l

—

(1175426) CD3 cells/100 lymphocytes in Blood

379

1.56

2.74

1.6

2.2

73.1

73.6

0.09

365

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

722

6429

1.14

2.72

1.7

1.5

1.4

2.00

632

5762

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.36

2.72

1.2

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

174

1.84

2.71

1.0

98.5

92.5

0.66

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.71

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.71

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

372

1.56

2.71

1.1

iu/ml

13.2

9.7

0.26

106

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

233

1.72

2.71

1.3

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

641

1.43

2.71

2.8

3.2

0.9

1.5

2.27

503

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

518

4508

1.16

2.70

3.2

2.9

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

159

1226

1.30

2.68

1.5

2.4

g/l

0.5

0.8

0.49

136

1077

(4015189)

105

2.10

2.68

1.7

2.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

145

1107

1.32

2.63

2.2

3.5

mg/l

43.5

103.9

0.62

114

899

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

160

1239

1.30

2.62

1.3

1.4

mg/l

495.4

491.8

0.03

154

1175

(3022621) pH of Urine by Test strip

382

3252

1.19

2.62

3.1

2.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

392

1.54

2.60

1.1

—

(44806071)

2.25

2.60

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

145

1110

1.31

2.59

2.2

3.5

mg/l

69.4

53.1

0.16

114

899

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

142

1084

1.32

2.59

1.4

2.3

g/l

0.0

0.20

132

1005

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

299

1.61

2.55

2.1

1.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

307

1.60

2.54

1.1

nmol/l

1.2

12.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

171

1.82

2.53

2.2

3.1

mg/l

10.5

7.8

1.35

135

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

238

1.69

2.53

1.2

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.23

2.53

1.0

1.3

—

102.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

347

1.56

2.53

1.3

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

232

1.69

2.48

1.2

1.1

u/l

17.5

19.0

0.15

179

(3017509) Phencyclidine [Presence] in Urine

2.32

2.48

1.0

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

109

2.02

2.45

1.0

1.1

90.2

81.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

109

2.02

2.45

1.0

1.1

83.7

73.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

128

972

1.32

2.44

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1001

0.70

2.40

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

632

1.40

2.39

1.1

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

441

1.48

2.39

1.3

1.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

334

0.48

2.37

23.1

18.2

nmol/l

1328.9

4264.6

0.52

326

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

118

1.95

2.34

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

127

970

1.32

2.34

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

507

4459

1.15

2.32

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

245

1.64

2.30

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

388

1.50

2.29

1.7

2.4

50.1

44.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

142

1808

0.78

2.26

1.4

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.07

2.26

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

163

1.78

2.26

2.6

3.9

—

(3013727) Leukocytes other/100 leukocytes in Blood

120

1.92

2.25

3.0

4.1

51.0

51.8

0.05

114

(3047352) Trisomy 18 risk [Likelihood] in Fetus

139

1769

0.78

2.22

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

114

867

1.32

2.19

4.8

5.8

iu/ml

850.3

754.4

0.06

116

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

195

1.70

2.18

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

101

755

1.34

2.18

1.5

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

234

1.63

2.16

1.2

1.1

u/l

85.6

76.0

0.46

187

(3005033) Fetal Nuchal fold Thickness US

139

1762

0.78

2.15

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

116

1.90

2.10

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

145

1.80

2.10

1.5

2.4

e6/l

168.0

145.3

0.25

(3024891) Influenza virus A+B Ag [Presence] in Specimen

168

1353

1.25

2.08

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

389

1.47

2.08

1.2

1.5

24.1

35.2

1.78

230

(3000850) Epithelial cells [#/volume] in Urine

1019

9406

1.10

2.06

2.6

2.4

e6/l

5.8

7.0

2.35

890

8204

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

117

1.88

2.05

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

374

1.47

2.05

1.4

1.3

e6/l

104696.5

63756.1

0.23

254

(3028433) Virus identified in Specimen by Culture

139

1.80

2.04

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

239

1.59

2.01

2.0

1.6

nmol/l

1.2

1.4

0.49

189

(3036603) Volume of Urine

287

1.54

1.99

1.8

1.5

2180.6

2058.5

0.19

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

180

1469

1.23

1.99

1.9

iu/l

3.8

4.5

0.70

588

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

493

1.40

1.99

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

296

1.52

1.97

1.4

1.6

u/l

7.1

5.7

0.13

147

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

657

1.34

1.95

1.8

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

175

1430

1.23

1.92

2.2

2.7

g/l

3.6

0.12

167

1364

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

138

1101

1.26

1.88

1.2

1.3

mmol/l

3.9

3.7

1.23

123

1031

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

448

1.41

1.88

1.8

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

166

1.69

1.87

6.3

9.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.09

1.86

1.7

1.6

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

4.17

1.82

1.0

1.1

u/ml

2.8

28.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

100

770

1.30

1.81

1.2

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

402

1.42

1.79

1.9

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

166

1361

1.23

1.79

3.2

2.9

—

(3009871) Measles virus Ab [Titer] in Serum

200

1.60

1.76

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

804

7396

1.10

1.76

4.4

4.5

ug/l

2.1

2.7

1.55

728

6643

(3009214) Lutropin [Units/volume] in Serum or Plasma

196

1637

1.20

1.76

1.3

u/l

11.4

11.5

0.04

159

1352

(3019832) Treponema pallidum Ab [Presence] in Serum

767

7041

1.10

1.75

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

112

880

1.28

1.75

2.7

3.8

kpa

8.5

0.03

102

814

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

139

1.73

1.75

1.1

u/ml

69.8

48.3

0.74

133

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

117

1.80

1.74

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

480

4298

1.13

1.73

1.5

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

372

1.43

1.72

1.7

2.2

13.4

0.01

178

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.85

1.71

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

421

3743

1.13

1.71

1.3

iu/l

27.4

29.7

0.75

380

3247

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

107

839

1.28

1.71

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

133

1.73

1.69

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

108

850

1.28

1.68

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

108

850

1.28

1.68

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

648

1.32

1.68

1.2

1.1

g/l

1.5

0.01

583

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

144

1173

1.23

1.67

2.7

3.6

mg/l

1.3

1.4

1.02

129

1092

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.16

1.66

1.0

1.1

—

(3004451) EKG impression Narrative

180

1.61

1.66

1.3

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

119

1.77

1.65

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

103

808

1.28

1.65

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

1.98

1.64

1.2

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

564

1.33

1.63

3.0

3.1

nmol/l

0.8

0.40

419

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

173

1.62

1.63

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

188

0.48

1.61

2.9

2.3

—

(4133840)

128

1.72

1.60

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

412

1.39

1.59

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

602

1.32

1.58

1.6

mmol/l

7.1

7.6

0.96

371

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

379

1.40

1.58

2.7

2.8

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.20

1.56

1.6

1.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

342

3020

1.14

1.56

1.5

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

239

1.51

1.56

1.1

1.3

u/l

163.5

274.3

1.49

224

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

114

914

1.25

1.55

3.2

2.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

263

2285

1.16

1.52

2.0

nmol/l

10.6

11.4

0.71

226

2005

(3011325) HIV 1+2 Ab [Presence] in Serum

2.59

1.51

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

138

1.67

1.51

1.1

—

(3002256) Pathology report gross observation

718

6623

1.10

1.51

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

266

1.47

1.50

1.0

88.8

90.0

0.10

208

(3017354) Segmented neutrophils/100 leukocytes in Blood

400

1.38

1.50

2.9

3.1

58.0

57.1

0.12

269

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

108

1.76

1.50

1.3

1.1

—

(3017569) Oxygen content in Arterial blood

184

0.49

1.49

3.2

2.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

317

1.42

1.47

1.5

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

505

1.33

1.47

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

411

1.37

1.45

1.0

1.1

—

(1002224) Polysomnography panel

256

2230

1.15

1.44

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

164

1.59

1.42

1.2

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

441

1.34

1.38

3.9

5.1

mmol/l

6.8

7.0

0.32

357

(3021901) Oxygen saturation in Capillary blood

669

1.27

1.38

2.5

3.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

206

1.51

1.37

1.2

1.4

2.4

3.7

—

(3008295) Osmolality of Serum or Plasma

433

1.34

1.37

2.4

1.4

mosm/kgh2o

276.7

279.3

0.37

344

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

416

1.35

1.37

1.0

1.1

mg/l

270.8

239.1

0.34

363

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

1.73

1.36

1.1

—

(3021788) Differential panel - Synovial fluid

777

1.25

1.36

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.75

1.34

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

235

2049

1.15

1.33

2.1

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

584

1.29

1.33

1.2

1.4

pmol/l

293.4

357.0

0.53

470

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.91

1.33

1.1

1.4

—

(3000991) Gas panel - Venous blood

367

3295

1.12

1.33

8.3

8.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

101

816

1.24

1.32

1.3

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

283

1.42

1.31

1.1

u/ml

1.5

17.9

—

(36304419) Bacteria [Presence] in Urine

1303

12384

1.07

1.28

3.0

2.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

171

1461

1.18

1.27

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.72

1.27

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.72

1.27

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.72

1.27

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.79

1.26

2.1

—

(3011648) Oxygen content in Venous blood

353

0.65

1.26

2.4

11.7

11.1

0.33

353

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

516

5618

0.91

1.26

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

4450

43789

1.06

1.25

16.8

14.4

13.6

0.24

4383

42865

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

170

1.53

1.25

1.2

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

129

1078

1.20

1.24

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

339

0.65

1.24

1.3

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.23

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

179

1.51

1.23

1.1

—

(3014271) Vancomycin [Susceptibility]

155

1.55

1.22

2.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.04

1.22

1.3

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.63

1.21

1.0

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

534

4917

1.09

1.21

20.6

19.7

inr

1.2

0.12

723

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

195

1692

1.16

1.21

1.7

1.8

g/l

1.6

1.5

0.04

171

1461

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

197

1.47

1.19

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

117

1.63

1.17

1.1

1.2

g/l

39.6

37.7

0.32

(40758292) HTLV I+II Ab panel - Serum

1.77

1.16

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

812

1.22

1.16

2.1

2.9

umol/l

34.6

35.4

0.09

696

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

1.6

—

25.8

—

(3017704) Immunofixation for Urine

190

1.48

1.16

1.5

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.50

1.15

2.4

—

(3023419) Bacteria identified in Sputum by Culture

491

1.29

1.14

3.3

2.6

—

(3020491) Glucose [Moles/volume] in Blood

386

1.32

1.14

1.7

1.6

mmol/l

7.0

6.4

0.67

278

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

168

1449

1.16

1.14

1.2

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

126

1.59

1.14

1.1

pmol/l

610.1

326.9

0.40

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

430

1.31

1.14

1.1

mg/l

35.6

40.1

0.35

362

(42529406) Shigella sp [Presence] in Stool by Culture

170

1469

1.16

1.13

1.2

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

869

8186

1.07

1.13

3.8

3.3

ng/l

212.9

363.2

1.39

584

5608

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

139

1182

1.18

1.12

2.7

3.5

u/ml

0.3

0.4

0.57

664

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.00

1.12

1.9

2.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.90

1.12

1.2

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

102

844

1.21

1.11

1.3

1.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

119

1.60

1.11

1.4

1.3

nmol/l

124.9

106.0

0.40

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

104

1.64

1.09

1.4

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

372

1.32

1.09

1.3

1.2

titre

40.0

190.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

381

1.31

1.08

1.1

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

698

6541

1.08

1.06

1.8

—

(3006653) Thiamine [Moles/volume] in Blood

262

1.38

1.05

1.5

1.4

nmol/l

134.2

134.9

0.04

262

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1256

12001

1.06

1.05

1.6

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

115

970

1.19

1.04

1.8

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

427

3927

1.09

1.02

1.8

1.7

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.92

1.02

1.3

1.2

—

577.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

359

1.31

1.01

3.1

3.7

mu/l

28.0

29.0

0.06

340

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.89

1.01

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.89

1.01

7.7

6.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

519

1.26

1.00

1.5

60.5

54.3

0.66

319

(3036489) Thrombin time

208

1842

1.13

1.00

2.0

2.1

21.9

21.3

0.35

162

1568

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.00

1.00

1.1

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.71

0.98

6.5

7.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

187

0.59

0.97

2.3

3.1

—

(3024263) Appearance of Synovial fluid

215

1.40

0.97

1.5

1.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

481

4461

1.08

0.96

2.4

2.3

u/l

40.8

49.1

0.27

410

3814

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

336

1.31

0.96

2.1

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

336

1.31

0.96

2.1

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

336

1.31

0.96

2.1

1.6

—

(3045414) Leukocytes [Presence] in Urine

253

2275

1.12

0.96

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

505

1.25

0.95

1.2

u/l

73.2

60.3

0.34

348

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.77

0.94

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

515

1.25

0.94

1.6

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

201

1.39

0.91

1.4

pmol/l

13.8

15.2

0.75

167

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

545

1.23

0.90

1.5

1.4

—

(1761868) Lipid panel - Serum or Plasma

2040

19806

1.05

0.90

3.2

2.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

810

1.19

0.90

1.3

1.2

u/ml

4.1

4.5

0.13

328

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.69

0.88

1.3

ng/l

18.7

73.3

—

(3018418) pH of Serum or Plasma

1394

13424

1.05

0.88

3.8

7.4

0.68

254

2612

(3042631) Mycobacterium sp identified in Specimen

521

1.23

0.87

3.4

2.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

128

1.49

0.85

2.0

1.9

umol/l

13.7

16.1

0.42

128

(3013293) Extractable nuclear Ab [Presence] in Serum

1.63

0.84

1.5

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

291

1.31

0.84

1.5

—

(3020891) Body temperature

132

1507

0.87

0.82

4.5

4.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

363

1.27

0.82

1.4

promille

1.2

0.03

278

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

342

0.73

0.82

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

121

1053

1.15

0.80

1.5

1.4

—

(3003338) MCHC [Mass/volume]

4472

45230

0.96

0.79

17.4

14.9

g/l

332.4

332.1

1.68

4441

44928

(40762814) Titanium [Mass/volume] in Blood

1.73

0.79

2.6

2.3

ug/l

3.1

3.9

—

(3044889) 12 lead EKG panel

3324

33814

0.96

0.79

3.4

3.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

117

1018

1.15

0.78

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.62

0.78

1.0

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

666

1.19

0.78

1.9

1.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.59

0.78

1.1

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

225

1.33

0.77

1.2

1.4

pmol/l

61.2

181.5

0.47

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

313

1.28

0.77

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.77

0.0

5.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

228

2070

1.11

0.77

2.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

332

3068

1.09

0.77

2.8

2.7

ng/l

153.3

151.0

0.04

306

2773

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

215

1947

1.11

0.76

1.5

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

358

3855

0.92

0.76

1.3

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.60

0.74

2.0

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

315

1.27

0.74

1.0

—

(3044941) Cell count panel - Synovial fluid

661

1.18

0.73

1.5

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

312

0.74

0.73

1.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.84

0.73

1.7

1.6

mg/l

0.5

1.3

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.84

0.73

1.7

1.6

mg/l

0.3

3.0

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.84

0.73

1.7

1.6

mg/l

1.2

2.1

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.84

0.73

1.7

1.6

mg/l

0.2

2.5

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.84

0.73

1.7

1.6

mg/l

0.4

1.5

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.84

0.73

1.7

1.6

mg/l

0.2

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

281

1.28

0.72

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.75

0.71

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.75

0.71

1.7

1.6

mg/l

0.6

1.7

—

(3026480) Teichoate Ab [Titer] in Serum

1.92

0.70

1.2

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

851

1.15

0.70

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

1105

10648

1.05

0.69

3.7

kg/l

1.0

0.03

222

1647

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

749

1.16

0.69

1.3

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

283

1.27

0.69

1.2

1.1

miu/ml

1441.2

1456.5

0.03

283

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.53

0.68

1.0

1.4

nmol/l

0.3

0.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

464

1.21

0.68

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

102

890

1.15

0.68

2.3

2.4

ug/min

91.2

78.4

0.13

544

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.85

0.68

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.49

0.66

1.0

1.2

mg/l

0.4

141.9

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.53

0.66

4.0

2.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

195

1776

1.10

0.65

1.8

—

(40757373) Influenza virus identified in Isolate

1.54

0.65

2.0

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

838

1.15

0.65

1.3

1.2

u/ml

4.4

3.1

0.29

262

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

532

5041

1.06

0.65

1.9

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.47

0.64

1.0

1.1

umol/24h

0.8

0.7

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.72

0.64

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

334

3118

1.08

0.64

2.2

ug/l

6.2

6.6

0.24

285

2730

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

125

1113

1.13

0.63

1.3

1.5

e6/l

901.9

4427.1

0.54

110

898

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.50

0.63

6.4

7.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1106

11444

0.96

0.63

3.6

3.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

243

1.28

0.62

2.1

1.7

u/field

2.1

2.6

0.19

168

(3000012) Reticulocyte production index

199

1.31

0.62

1.0

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

160

1448

1.11

0.62

2.3

2.6

178.5

182.5

0.24

149

1383

(3051651) Icteric interference index of Serum or Plasma

280

1.25

0.60

4.8

3.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.60

0.0

3.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.57

0.60

15.6

9.5

mmol/l

5.2

5.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.60

0.0

3.6

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.60

0.0

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

247

2288

1.08

0.59

1.7

mg/l

3.6

3.3

0.23

192

1598

(3047189) Immunofixation for 24 hour Urine

174

0.69

0.58

1.3

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

110

978

1.13

0.58

1.6

1.4

u/ml

102.5

113.8

0.66

211

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.58

0.0

1.9

—

0.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

219

1.28

0.58

2.5

1.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.46

0.58

1.2

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

124

1113

1.12

0.57

1.2

1.4

e6/l

12.3

29.6

1.24

104

850

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

374

0.80

0.55

4.9

6.7

—

(3022475) Manganese [Moles/volume] in Blood

1.62

0.55

1.2

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

226

2438

0.92

0.55

8.8

8.9

94.1

0.06

226

2429

(4306422)

832

1.13

0.55

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

357

1.21

0.55

1.3

1.4

nmol/l

1.4

0.02

320

(3006922) Hepatitis E virus Ab [Presence] in Serum

348

1.21

0.54

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.45

0.53

1.0

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

106

949

1.12

0.52

1.9

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

433

1.18

0.52

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

259

1.24

0.52

1.0

ng/l

370.1

342.5

0.20

178

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

114

1026

1.11

0.52

1.2

u/ml

251.5

273.9

0.43

665

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

304

0.79

0.51

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

206

1.26

0.50

2.6

2.4

umol/l

53.6

51.5

0.14

178

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.47

0.50

1.2

1.1

ug/l

2.7

498.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

335

0.81

0.49

1.8

1.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

261

1.23

0.49

1.0

ng/l

727.3

737.0

0.06

176

(3043409) Potassium [Moles/volume] in Arterial blood

101

1122

0.90

0.48

4.0

mmol/l

3.8

0.88

1061

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

111

0.63

0.48

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

253

2371

1.07

0.48

1.5

1.6

mu/l

256.7

305.4

3.08

220

2123

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

204

1897

1.08

0.47

5.4

4.6

mmol/l

23.5

24.2

2.12

181

1723

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

804

1.12

0.47

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.49

0.47

1.6

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

263

1.22

0.47

1.0

ng/l

51.7

47.9

0.17

176

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.46

0.46

2.0

2.5

u/field

0.6

0.7

—

(3019174) dRVVT (LA screen)

1.43

0.46

1.6

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

320

0.81

0.45

1.3

3.1

—

(4281824)

653

0.87

0.45

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.40

0.45

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

219

1.23

0.45

2.5

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

219

1.23

0.45

2.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

219

1.23

0.45

2.5

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

450

1.16

0.44

1.4

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

525

1.14

0.44

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.40

0.44

1.7

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

714

1.12

0.44

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

109

1198

0.91

0.44

1.4

1.5

nmol/l

0.4

0.11

937

(3048879) Bone marrow aspiration report

1.37

0.43

1.5

2.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

116

1269

0.91

0.43

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.61

0.43

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

490

0.86

0.43

1.1

1.2

—

(3045142) Bone marrow Pathology biopsy report

436

0.85

0.42

1.2

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

359

1.17

0.42

1.4

e6/l

32543.8

73747.4

0.87

204

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.56

0.42

1.4

2.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

812

1.11

0.42

1.1

113.8

118.2

0.63

730

(1617658) Protocol used for examination of sentinel lymph nodes

510

0.86

0.42

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.35

0.41

1.7

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

169

1572

1.08

0.41

2.1

2.3

92.5

93.5

0.23

152

1453

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.52

0.41

1.2

3.4

mg/l

1.9

2.2

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.47

0.40

1.0

—

23.7

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.47

0.40

1.2

1.1

—

5.2

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.47

0.40

1.0

—

30.3

—

(3001729) Color of Synovial fluid

1.47

0.40

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

512

1.13

0.39

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

108

989

1.09

0.39

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

196

1.23

0.39

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

187

1.23

0.38

1.8

2.0

—

(3020650) Glucose [Presence] in Urine

151

1.26

0.38

1.2

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.36

0.38

1.4

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

107

1166

0.92

0.38

2.4

2.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

794

8171

0.97

0.38

2.8

mmol/l

2.4

0.42

689

7115

(21494434) Karyotype in Bone marrow

312

0.83

0.37

1.1

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

411

1.14

0.37

1.4

2.3

nmol/l

17.6

18.8

0.52

391

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

170

1.24

0.37

2.9

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

161

1.24

0.37

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

207

1.21

0.36

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

171

1.23

0.35

7.4

5.6

mg/l

56.5

61.5

0.15

127

(4034850)

150

1605

0.93

0.35

7.8

8.5

—

(3033799) Differential panel - Peritoneal fluid

125

0.72

0.35

2.8

2.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

823

1.09

0.35

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.36

0.34

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

467

4505

1.04

0.34

3.2

3.9

ug/l

18.8

27.9

0.38

358

3491

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

118

1.27

0.33

1.0

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

615

1.11

0.33

1.4

—

(3003694) ABO and Rh group [Type] in Blood

1524

15503

0.98

0.33

1.5

—

(3014891) Appearance of Pleural fluid

1.30

0.33

1.5

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

663

1.10

0.33

2.4

2.5

—

(3033658) Prothrombin time (PT) actual/Normal

1224

12002

1.02

0.32

3.8

3.6

96.0

94.4

1.48

1196

11679

(3019060) Gas panel - Arterial blood

234

2459

0.95

0.32

4.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

914

1.08

0.32

2.0

2.1

g/l

131.8

130.0

0.24

658

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

229

1.18

0.32

1.4

1.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

154

0.78

0.32

1.0

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

542

1.11

0.30

1.2

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

175

0.80

0.30

1.4

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

147

1.23

0.30

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.33

0.30

1.5

1.2

—

(4268621)

562

1.10

0.30

2.5

2.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

287

1.15

0.30

1.5

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

220

2309

0.95

0.29

1.4

1.5

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.25

0.29

2.7

3.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

355

3683

0.96

0.29

7.8

7.7

g/l

121.3

121.4

0.04

346

3533

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

612

1.10

0.28

1.1

1.3

—

(4035726)

412

4257

0.97

0.28

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.29

0.28

2.8

3.1

—

(3034426) Prothrombin time (PT)

186

1.18

0.27

1.5

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

460

1.11

0.27

1.1

—

(40761536) Microorganisms panel - Urine sediment

453

4396

1.03

0.26

4.3

3.5

—

(3045788) Cell count panel - Pleural fluid

329

1.13

0.25

1.4

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

263

2529

1.04

0.25

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

170

1.18

0.24

2.9

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

170

1.18

0.24

2.9

1.9

—

(3041806) Other cells [#/volume] in Blood by Manual count

244

0.86

0.24

1.5

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

190

0.84

0.23

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

619

0.92

0.23

1.2

u/l

19.7

30.2

0.83

531

(3043410) Blood group antigens tested for on Red Blood Cells

144

1.18

0.22

2.4

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

144

1.18

0.22

1.6

1.9

—

(3023410) Appearance of Cerebral spinal fluid

516

1.09

0.22

1.3

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

1.22

0.21

2.7

3.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

1.22

0.21

2.7

3.6

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

1.9

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.5

—

28.0

—

(3035880) pH of Pleural fluid

182

1.15

0.21

1.1

1.3

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.9

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

119.4

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.21

0.0

1.0

—

12.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.8

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.3

—

(3025130) Human papilloma virus identified in Specimen

1037

0.94

0.20

1.8

—

(3016502) Oxygen saturation in Arterial blood

382

3923

0.97

0.20

7.5

7.4

95.9

0.02

366

3771

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

156

1493

1.05

0.20

2.7

3.5

u/ml

3619.3

2291.7

0.23

140

1265

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

5.0

—

0.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.20

0.0

7.6

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.25

0.20

1.0

1.1

umol/24h

1.8

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

374

1.10

0.20

1.2

1.1

—

(40768793) Breast Pathology biopsy report

141

1474

0.96

0.19

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

396

0.91

0.19

1.4

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

500

1.08

0.19

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

127

1.18

0.19

1.2

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.18

0.19

1.5

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

1023

0.95

0.19

1.8

2.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.13

0.18

1.5

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

382

3727

1.03

0.18

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

1329

13136

1.01

0.18

4.0

3.7

estimate

0.0

1.98

493

4652

(3035637) Corticotropin [Mass/volume] in Plasma

628

1.07

0.18

1.3

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

415

0.92

0.18

3.1

2.8

mg/l

18.5

48.0

1.10

291

(1616796) Gas panel - Central venous blood

909

0.95

0.18

3.4

3.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.21

0.18

1.6

—

(3044007) Cell count panel - Peritoneal fluid

121

0.83

0.18

2.4

2.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.17

0.17

2.7

2.4

umol/l

1.2

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.17

0.17

2.0

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

275

2673

1.03

0.17

1.5

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.11

0.17

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

173

0.87

0.16

3.2

2.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.18

0.16

1.0

2.0

—

(40768441) Liver Pathology biopsy report

371

0.92

0.16

1.1

1.4

—

(3047181) Lactate [Moles/volume] in Blood

135

1297

1.04

0.16

5.9

5.2

mmol/l

1.2

1.3

0.10

127

1123

(4211845)

267

0.90

0.16

5.4

2.8

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

263

1.10

0.16

2.1

2.7

40.3

40.7

0.03

(3037692) Legionella sp identified in Specimen by Organism specific culture

141

0.85

0.16

1.9

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

146

1516

0.96

0.16

1.4

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

106

1013

1.05

0.16

1.9

1.8

—

(44790047)

476

1.07

0.16

1.6

1.5

—

(44806118)

476

1.07

0.16

1.6

1.5

—

(44790048)

476

1.07

0.16

1.6

1.5

—

(44790049)

476

1.07

0.16

1.6

1.5

—

(3010421) pH of Blood

105

1098

0.96

0.16

3.6

3.4

7.4

0.19

922

(40767503) Oxygen content in Capillary blood by calculation

847

1.05

0.16

2.3

16.9

16.4

0.44

419

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.10

0.15

1.5

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

637

0.94

0.15

4.2

5.2

umol/l

353.2

369.6

0.38

546

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

216

1.11

0.15

2.7

5.8

—

151.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

209

2152

0.97

0.15

1.3

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

121

1.16

0.15

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

595

0.94

0.15

3.1

4.7

u/ml

33.6

96.8

2.04

188

(1001926) Buprenorphine [Presence] in Urine by Screen method

179

1847

0.97

0.15

1.6

2.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

213

0.89

0.15

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

209

2150

0.97

0.14

1.3

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.81

0.14

1.3

1.6

—

(3022689) Creatine [Moles/volume] in Urine

131

1.15

0.14

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

179

1.12

0.14

1.3

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

179

1.12

0.14

1.3

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

160

1.13

0.14

7.3

4.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.82

0.13

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

348

3550

0.98

0.13

3.3

u/ml

38.7

47.4

0.50

336

3427

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

128

1236

1.04

0.13

1.8

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

213

2077

1.03

0.13

8.3

9.1

mmol/l

24.2

24.3

0.07

200

1953

(3042733) HLA Ab [Presence] in Serum

148

0.88

0.12

8.2

5.3

—

(3024928) Oxygen saturation in Venous blood

834

0.96

0.12

4.6

3.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

133

1.13

0.12

1.1

1.2

—

(3025577) Chromium [Mass/volume] in Blood

220

1.09

0.11

2.3

2.1

ug/l

2.8

2.6

0.07

194

(21494755) Public health laboratory ask at order entry panel

610

6178

0.99

0.11

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

599

0.95

0.11

1.3

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

209

2139

0.98

0.11

1.3

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

117

1208

0.97

0.11

1.3

1.2

—

(3016879) Cocaine [Presence] in Urine

226

2212

1.02

0.11

1.6

2.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

353

3472

1.02

0.11

6.7

6.8

mmol/l

1.3

0.42

344

3350

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

358

3639

0.98

0.11

2.6

2.5

ml/min/173m2

71.4

70.6

0.16

139

1387

(43055514) Macroprolactin [Presence] in Serum or Plasma

163

1.10

0.10

1.3

1.4

—

(40768446) Kidney Pathology biopsy report

163

1.10

0.10

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

218

2134

1.02

0.10

9.6

9.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

210

2146

0.98

0.10

1.3

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

202

1.09

0.10

1.9

1.8

umol/l

150.7

162.2

0.07

108

(3035320) C reactive protein [Mass/volume] in Body fluid

368

1.06

0.10

2.8

2.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

234

2386

0.98

0.10

6.7

6.4

mmol/l

24.7

24.5

0.32

216

2202

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

155

0.90

0.09

2.1

2.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

176

1797

0.98

0.09

1.5

1.3

—

(40768800) Prostate Pathology biopsy report

431

0.95

0.09

1.1

1.2

—

(3042517) Benzodiazepines panel - Urine

1.09

0.08

1.8

2.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

292

1.06

0.08

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

253

1.07

0.08

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

410

1.05

0.08

1.3

1.4

e6/l

3174.6

2368.0

0.36

299

(3000285) Sodium [Moles/volume] in Blood

1.03

0.08

1.2

1.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

443

4480

0.99

0.08

7.0

6.9

kpa

5.0

5.1

0.71

423

4278

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.14

0.08

1.3

2.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.08

0.08

1.9

2.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

443

4478

0.99

0.07

7.0

6.9

kpa

12.3

12.9

1.72

424

4273

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.05

0.07

1.4

31.5

24.1

—

(3012441) Differential panel - Pleural fluid

333

1.05

0.07

1.3

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

429

4335

0.99

0.07

2.7

2.9

ug/l

0.8

0.7

0.37

266

2715

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

109

1116

0.98

0.07

1.2

1.3

ug/l

3.1

3.8

0.88

1003

(40757494) Bilirubin.total [Moles/volume] in Blood

196

1.07

0.07

1.5

2.4

umol/l

13.1

25.2

—

(3000764) Benzodiazepines [Presence] in Urine

244

2406

1.01

0.07

1.6

2.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.87

0.06

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

101

0.89

0.06

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

258

2548

1.01

0.06

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

197

1.07

0.06

1.5

—

(40768806) Pleura Pathology biopsy report

355

1.04

0.06

1.4

1.5

—

(3028300) Cannabinoids [Presence] in Urine

246

2431

1.01

0.05

1.6

2.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

263

0.95

0.05

1.0

1.3

—

65.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

202

0.94

0.05

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

881

1.02

0.05

2.9

3.4

u/ml

167.8

597.7

0.73

804

(4027681)

346

1.04

0.05

1.2

—

(3024471) HLA-A [Type]

151

0.93

0.05

1.0

—

(3027008) Opiates [Presence] in Urine

245

2424

1.01

0.05

1.6

1.9

—

(3024932) HLA-DR beta [Type]

150

0.93

0.04

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

403

4057

0.99

0.04

1.4

1.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

101

1.09

0.04

1.2

1.3

mmol/l

3.3

3.1

0.06

(21494890) Protein electrophoresis panel - 24 hour Urine

368

1.03

0.04

2.4

2.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

341

0.97

0.03

1.1

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

330

0.97

0.03

1.3

1.4

mmol/l

6.4

0.02

312

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

589

5909

1.00

0.02

3.7

4.0

22.0

21.6

0.19

255

2694

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

202

1.04

0.02

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

451

1.02

0.02

4.6

3.2

—

(3015183) Erythrocyte sedimentation rate

312

1.03

0.02

1.4

1.2

—

(3018572) Chloride [Moles/volume] in Blood

908

0.99

0.01

6.4

6.1

mmol/l

105.3

105.6

0.26

800

(3039000) Anion gap in Blood

907

0.99

0.01

6.3

6.1

mmol/l

10.7

11.2

0.89

799

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

116

0.95

0.00

1.1

—

(3006462) Nitrate [Presence] in Urine

246

0.98

0.00

5.3

2.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

326

0.98

0.00

1.1

u/l

1.1

0.26

134

(3011288) Drugs identified in Urine by Screen method

160

1606

1.00

0.00

2.0

3.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

162

0.99

0.00

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

105

0.95

0.00

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

532

1.00

0.00

1.2

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

295

0.98

0.00

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

295

0.98

0.00

1.0

1.2

u/l

112.8

80.7

1.05

263

(40765096) Chromosome analysis panel by Banding

116

1.03

0.00

1.2

1.1

—

(40761535) Cells panel - Urine sediment

353

3525

1.00

0.00

3.6

3.3

—

(4198724)

247

1.01

0.00

1.8

3.5

—

(3027944) Amphetamines [Presence] in Urine

239

2386

1.00

0.00

1.4

2.1

—

(3012501) Base excess in Blood by calculation

937

1.00

0.00

3.7

3.5

mmol/l

2.5

0.04

607

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

201

1.00

0.00

1.1

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.88

0.00

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

0.94

0.00

1.0

1.5

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

37.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3003396) Base excess in Arterial blood by calculation

446

4460

1.00

0.00

7.0

6.9

mmol/l

0.9

1.0

0.14

345

3446

(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma

0.00

0.0

2.6

—

285.8

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

7.7

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.97

0.00

8.3

6.8

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.98

0.00

1.2

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

6.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.00

0.00

5.2

2.3

mg/l

1.1

1.7

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.0

1.0

—

162.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.86

0.00

2.8

2.5

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.4

—

2424.7

—

(40762365) Oxygen content in Arterial blood by calculation

0.90

0.00

1.8

ml/dl

15.6

15.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ALLERGICCONTACT and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_ALLERGICCONTACT	0.967 [0.87, 1.07]	0.537
Birth year	0.991 [0.98, 1.0]	0.041

During the follow-up period (1.1.1998 — 31.12.2019), 1885 out of 27327 females with L12_ALLERGICCONTACT died.

Males

Parameter	HR [95% CI]	p-value
L12_ALLERGICCONTACT	1.022 [0.92, 1.14]	0.698
Birth year	0.987 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 1054 out of 10081 males with L12_ALLERGICCONTACT died.

Mortality risk

Mortality risk for people of age

years, who have L12_ALLERGICCONTACT.

N-year risk	Females	Males
1	0.078%	0.198%
5	0.533%	1.186%
10	1.338%	2.921%
15	2.52%	5.536%
20	4.343%	9.566%

Relationships between endpoints

↥

Index endpoint: L12_ALLERGICCONTACT – Allergic contact dermatitis

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Allergic contact dermatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints